Track market-moving stories before they get noisy

MIAMI, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (Nasdaq: WRAP) (“WRAP” or the “Company”), a global public safety technology company delivering intelligent detection, orchestration and response solutions designed for the next generation of human-centered public safety, today announced the expansion of its strategic relationship with Frenel Imaging Ltd. (“Frenel”) into a broader commercial framework through which advanced technologies sourced by Frenel can be brought into WRAP’s WrapShield™ platform and commercialized across United States and NATO markets.

The first capability being advanced under that framework is laser directed energy for counter unmanned aircraft systems (C-UAS), in which Frenel’s passive thermal polarimetric detection and classification technology is being integrated as the perception and tracking layer for laser effector systems developed by an established directed-energy manufacturer.

The announcement comes five days after WRAP disclosed a $12.0 million institutional financing. The Company now looks to expand WrapShield across a larger public safety, defense and enterprise market. This is the first capability advanced under that initiative.

Laser Directed Energy: Mobile, Scalable and Built for Repeated Engagement

The directed-energy technology being advanced through the Frenel relationship includes a family of fiber-laser counter-UAS capabilities designed to address different operational environments.

Approximately 3 kW man-portable configuration designed for a smaller, deployable counter-UAS footprint.Approximately 6 kW mobile vehicle or pickup-mounted configuration designed to move with the mission and provide counter-UAS protection across changing operating areas.Approximately 9–12 kW stationary or fixed-site configuration designed for protection of installations, infrastructure and other persistent operating locations.Integrated gimbal and fire-control subsystems supporting precision pointing, tracking and controlled target engagement.Dazzler capability as part of the associated directed-energy product architecture.Speed-of-light energy delivery once a target has been detected, tracked and positively authorized for engagement.Rapid repeated-engagement capability, reducing dependence on a finite inventory of traditional kinetic interceptors.Magazine depth primarily constrained by available power rather than interceptor inventory, creating fundamentally different economics for sustained counter-UAS operations.Mobile employment, allowing directed-energy response to move with operational requirements rather than remaining limited to permanent defensive positions.Integration with external sensing, tracking and command-and-control, allowing the laser to operate as an effector within a broader coordinated response architecture rather than as a standalone system. The underlying technology documentation identifies approximately 3 kW man-portable, 6 kW vehicle-mounted and 9–12 kW fixed-site fiber-laser systems together with associated dazzler, gimbal and fire-control subsystems.

For WRAP, the mobile configuration is particularly important.

The Company sees an emerging requirement for counter-UAS protection that can move with the mission: supporting forward locations, border sectors, critical infrastructure and specialized tactical operations where the threat can shift faster than permanent defensive infrastructure can be deployed.

WrapShield Has Been Compounding in Public

WRAP’s recent expansion has been guided by a single operating principle: Lowest Reasonable Response™ - applying the least amount of force reasonably capable of resolving a situation, as early as possible and under human authority. Over the past several weeks, the Company has systematically expanded the WrapShield™ architecture across technology, training, private security, public safety, and new markets, building a coordinated platform designed to detect earlier, respond more proportionately, and create greater accountability across every layer of the response.

July 15 — Expanded Non-Lethal Response: Introduced the Wraptor MX™ multi-shot platform, expanding WrapShield’s non-lethal response layer to three coordinated delivery mechanisms.July 30 — Expanded into Private Security: Extended WrapReality™ into the private security market through a deployment with Stark Security.August 7 — Launched WrapTactics™: Completed the training foundation of WrapShield with the enterprise launch of WrapTactics™, an LMS designed to make training, policy, and operational readiness accountable and auditable across the architecture.August 11 — 103% Year-Over-Year Q2 Revenue Growth: Reported second-quarter financial results reflecting 103% year-over-year revenue growth, alongside the ATF determination that the BolaWrap® 150 is neither a firearm nor a weapon.August 13 — Launched Safe Response with XINSURANCE: Expanded into the approximately 1.28 million-person U.S. private security workforce through a certified Safe Response standard combining technology, training, and insurance alignment.August 14 — Selected for Florida Teacher Safety Initiative: Selected to support a state-funded teacher safety initiative in Florida, further extending WRAP’s training capabilities into community safety and preparedness.August 19 — Secured $12.0 Million in Growth Capital: Announced a $12.0 million institutional financing. The Economics of Drone Defense Have Inverted

Low-cost drones are changing the economics of defense. Inexpensive, increasingly autonomous aircraft can force defenders to expend costly, finite interceptors, while emerging platforms can operate without traditional RF links. Directed energy changes this equation by replacing expensive interceptor inventory with energy, creating the potential for dramatically lower cost per engagement and greater magazine depth.

The Drone Threat Is Moving Beyond the Battlefield

Drone threats are rapidly migrating from military environments into borders, critical infrastructure, correctional facilities, major events, and public safety. As counter-UAS authority expands beyond traditional federal and military users, WRAP believes a significant new market is emerging for technology that can bring proven detection and response capabilities into state, local, and specialized law enforcement environments.

Price Point Determines Market Scale

Counter-UAS capability has historically been priced around the customers able to afford it. Major military installations and combatant commands can support multimillion-dollar fixed-site systems, expensive interceptors, and the infrastructure required to operate them. But the emerging threat is distributed across a much larger global footprint, including forward operating locations, temporary bases, borders, ports, allied military installations, critical infrastructure, and public safety environments. Many of these customers, particularly smaller U.S. agencies, allied and partner nations, and forces operating across multiple dispersed locations, cannot economically deploy traditional counter-UAS infrastructure everywhere it may be needed. The opportunity is therefore not simply to build another high-end counter-UAS system. It is to drive down the acquisition, deployment, and operating costs sufficiently to make effective protection scalable across a much larger domestic and international market.

Directed energy has the potential to change those economics at both the military and public safety levels. A system whose magazine depth is constrained principally by available power rather than expensive interceptor inventory can reduce cost per engagement, support repeated training, and remain operational through sustained or simultaneous attacks. When combined with lighter, mobile configurations that can move with military units, protect temporary or expeditionary locations, integrate onto ground robotic platforms, or be deployed by state and local agencies, the addressable market expands considerably. WRAP believes the winning counter-UAS architecture will not be defined by performance alone. It will be defined by the combination of performance, mobility, affordability, interoperability, and an operating cost that allows U.S. forces, allied nations, and public safety agencies to buy it, train with it, deploy it at scale, and actually use it when needed.

Beyond Counter-UAS: A New Tool for Tactical Law Enforcement

WRAP believes the approximately 3 kW portable architecture may also create a new category of directed-energy capability for specialized law-enforcement and SWAT operations. The Company intends to evaluate applications including standoff breaching, lock and barrier removal, and other controlled-access requirements where increasing the distance between an operator and a physical hazard may improve tactical options.

The same portable architecture may also be appropriate for integration onto ground robotic systems, allowing directed energy to be remotely positioned or delivered into environments where sending an officer, agent or service member may create unnecessary exposure.

For WRAP, this illustrates the larger WrapShield opportunity: a technology sourced for one demanding mission can become a common capability across defense, homeland security, tactical law enforcement and unmanned systems.

Extending the WrapShield™ Response Layer

WrapShield is WRAP’s integrated public safety and defense architecture, organized around three layers across 6 tiers. ‘Detect’ provides passive sensing and early identification, including Frenel’s polarimetric imaging and edge processing. ‘Orchestrate’ provides command, coordination and human-supervised decision making. ‘Respond’ provides an expanding family of response capabilities selected according to the threat, the environment, the mission and the applicable authority.

Until now the response layer has addressed threats at human scale and human range, spanning handheld restraint, multi-shot delivery through Wraptor MX and remotely delivered response through unmanned platforms. Directed energy extends that layer into a different threat class entirely and introduces the first non-kinetic effector in the architecture. The tiered logic does not change. It simply now reaches the air.

Operationally the full chain runs as follows:

Detect, classify, track, prioritize, hand off, authorize, engage, assess.

The laser therefore functions as one response option inside a coordinated architecture operating under positive human control, rather than as a standalone weapon. Authorization remains a human decision at every tier, which is the same principle that governs every other capability WRAP fields.

Directed energy is not the correct answer in every environment, and WRAP does not present it as one. Energy based defeat is best suited to installations, border sectors, critical infrastructure and controlled operating areas where standoff and clear engagement geometry can be established. In dense, populated settings the calculus changes, and considerations including falling debris and collateral risk become decisive. That is precisely why the architecture is tiered to provide the flexibility to switch between “soft” and “hard” energy-based interception, and why authorization always remains with a human being. The value of a coordinated response layer is not that it offers a single answer, rather the fact that it offers the appropriate one and can tell an operator which is which.

Frenel as a Technology Pipeline Into WrapShield™

The larger strategic opportunity for WRAP is not limited to directed energy.

Under the expanded framework, qualifying technologies for which Frenel obtains the necessary rights can be introduced into the WRAP relationship for potential inclusion within WrapShield and commercialization through WRAP’s established channels. The structure is designed to create a repeatable technology pipeline rather than a one-time licensing transaction.

WRAP intends to use that pipeline to identify advanced capabilities developed against demanding operational requirements, including technologies developed and matured against real security and battlefield requirements, and to perform the work required to turn them into programs that United States and NATO customers can actually buy. That work includes systems integration, software and command-and-control interfaces, engineering adaptation, productization, United States sourcing and manufacturing where appropriate, cybersecurity, export control compliance, federal procurement readiness, testing, certification, training and sustainment.

It is deliberately unglamorous work, and it is the reason the model is difficult to replicate. Advanced technology developed elsewhere rarely fails on merit in the United States market. It fails on qualification, compliance, supply chain control and the absence of a party willing to carry it through federal procurement. WRAP is aiming to build itself to be that party.

Executive Commentary

“The math of drone defense is upside down. An adversary can field increasingly capable drones at a fraction of what it costs to defeat them with traditional interceptors,” said Jared Novick, President and Chief Operating Officer of WRAP. “Directed energy flips that equation, but only if you can aim it. A laser has to hold a beam on a small moving object long enough to do the work, and that makes the sensing layer the hardest part of the problem rather than the easiest. What we hold through Frenel is precisely the layer that makes a low-cost effector usable in the conditions where these engagements actually happen. And cost is not an abstraction here. A department will not authorize a response that costs more to use than its annual training budget. Getting both numbers down—the cost of the system and the cost of the shot—is what determines whether this capability remains concentrated at major installations or can scale across borders, forward locations, allied forces and public safety.”

“WRAP and Frenel began with a differentiated sensing technology, and the opportunity was always larger than that,” said Scot Cohen, Chairman and Chief Executive Officer of WRAP. “Our expanded framework creates a path to bring additional advanced technologies into the relationship where we have the rights to do so, with WRAP providing the integration and commercialization capability around what United States and NATO customers actually require. Directed energy is a powerful demonstration of that model, because it takes WrapShield from seeing a threat earlier to coordinating an effective response against a class of threat we could not previously reach.”

The WrapShield™ Thesis

WRAP believes the convergence of public safety, homeland security, defense, border security, critical infrastructure and autonomous systems is creating a new technology market, and that the defining position in that market will not belong to the best individual sensor or the cheapest individual effector. It will belong to whoever owns the layer where perception and response have to agree.

The Company’s strategy is to build WrapShield as the integration and commercialization architecture across that convergence, combining differentiated sensing, intelligence, command and control, and response technologies around specific customer and mission requirements. The model is demanding to execute:

Identify differentiated technologies capable of solving operational problems that current tools do not solve.Integrate them into a coordinated Detect, Orchestrate and Respond architecture rather than selling them as separate components.Invest selectively where United States adaptation, qualification, sourcing, manufacturing or support creates strategic or commercial value.Build resilient United States supply and support infrastructure where the mission or the customer requires it.Support United States federal customers including the Department of War and the Department of Homeland Security against rapidly evolving threats.Commercialize globally through the markets, partners and channels best suited to each opportunity.Accelerate advanced technologies to the operators who need them most through vertical integration, cost discipline and a training-first foundation. WRAP does not intend to relocate technology or manufacturing to the United States for its own sake. The Company intends to build United States controlled technology, supply chain and support capability where doing so creates strategic value, including where required to serve federal customers, to satisfy security, procurement or restricted value chain requirements, to improve supply chain resilience, to provide domestic sustainment and lifecycle support, or to address the scale of the United States market.

Frenel expands the technology pipeline and R&D resources. WRAP determines where to invest and then streamlines and integrates the capabilities through WrapShield. Where the mission requires it, WRAP intends to build the American infrastructure necessary to support the American customer.

About Wrap Technologies, Inc.

Wrap Technologies, Inc. (Nasdaq: WRAP) is a global public safety technology company delivering intelligent detection, orchestration and response solutions designed for the next generation of intelligent, human-centered public safety. The Company’s WrapShield™ platform unifies detection, orchestration and response into an integrated, human-supervised architecture spanning law enforcement, homeland security, defense, enterprise and critical infrastructure customers. Powered by the BolaWrap® 150, Wraptor MX™, WRAP Reality™, the WrapTactics™ learning management system and Frenel TPiCore® polarimetric sensing, WRAP builds on the principle that technology and trained human judgment must advance together. For Humans, By Humans. WRAP is headquartered in Miami, Florida. For more information visit www.wrap.com.

About Frenel Imaging Ltd.

Frenel Imaging Ltd. develops and licenses the TPiCore® polarimetric image signal processing framework and associated polarimetric thermal, near-infrared and daylight sensors, providing passive day-and-night detection, classification and discrimination of unmanned aircraft and other targets, including against cluttered and below-skyline backgrounds and without radio-frequency emission.

Forward Looking Statements

This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expanded framework with Frenel Imaging Ltd., the development, integration, qualification and commercialization of directed-energy counter-UAS capability, the anticipated use of proceeds from the Company’s recent financing, the expansion of the WrapShield platform and its response layer, potential tactical law-enforcement, standoff breaching, lock or barrier removal and ground-robotic applications, potential future technologies and partnerships, addressable markets, and the Company’s strategic direction. The integration described in this release is in a development phase, has not completed demonstration or qualification, and no assurance can be given that it will be completed on the anticipated timeline or at all. Definitive agreements relating to the underlying collaboration have not been executed and there is no obligation on any party to enter into them. Statements are based on current expectations and assumptions subject to risks and uncertainties, including the pace of customer and agency adoption, the timing and outcome of federal procurement and export control processes, the availability and terms of technology partnerships, regulatory developments, competitive conditions, and the Company’s ability to attract and retain personnel. Actual results could differ materially from those expressed or implied. WRAP undertakes no obligation to update or revise any forward looking statement, and investors are cautioned not to place undue reliance on them.

Investor Relations Contact:
(800) 583-2652
[email protected]
Wrap.com

Bank of New York Mellon Corp purchased a new stake in shares of International Flavors & Fragrances Inc. (NYSE:IFF – Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 1,550,018 shares of the specialty chemicals company’s stock, valued at approximately $122,792,000. Bank of New York Mellon Corp owned approximately 0.61% of International Flavors & Fragrances at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the stock. Tema ETFs LLC increased its holdings in shares of International Flavors & Fragrances by 9.4% in the second quarter. Tema ETFs LLC now owns 5,078 shares of the specialty chemicals company’s stock valued at $402,000 after purchasing an additional 435 shares during the period. Peoples Bank KS increased its holdings in International Flavors & Fragrances by 5.1% in the 2nd quarter. Peoples Bank KS now owns 4,686 shares of the specialty chemicals company’s stock worth $371,000 after buying an additional 228 shares during the period. Contravisory Investment Management Inc. purchased a new position in International Flavors & Fragrances during the 2nd quarter worth approximately $1,112,000. HF Advisory Group LLC raised its position in International Flavors & Fragrances by 1.3% during the 2nd quarter. HF Advisory Group LLC now owns 17,847 shares of the specialty chemicals company’s stock worth $1,414,000 after buying an additional 233 shares during the last quarter. Finally, Everhart Financial Group Inc. acquired a new stake in International Flavors & Fragrances during the 2nd quarter valued at approximately $208,000. 96.02% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets Several research analysts recently issued reports on IFF shares. Morgan Stanley raised their target price on shares of International Flavors & Fragrances from $93.00 to $95.00 and gave the stock an “overweight” rating in a report on Wednesday, July 1st. BNP Paribas Exane upped their price target on shares of International Flavors & Fragrances from $85.00 to $95.00 in a report on Thursday, May 7th. Rothschild & Co Redburn cut their price target on International Flavors & Fragrances from $74.00 to $71.00 in a research report on Friday, May 8th. Benchmark lifted their price objective on International Flavors & Fragrances from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on International Flavors & Fragrances from $95.00 to $90.00 and set a “buy” rating for the company in a report on Monday, June 1st. Thirteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $92.16.

View Our Latest Stock Report on International Flavors & Fragrances Insider Transactions at International Flavors & Fragrances In related news, EVP Michael Deveau sold 8,825 shares of the stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $85.55, for a total value of $754,978.75. Following the completion of the transaction, the executive vice president directly owned 5,199 shares of the company’s stock, valued at approximately $444,774.45. This represents a 62.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider De Mendonca Ana Paula Teles sold 5,718 shares of the firm’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $83.19, for a total value of $475,680.42. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 15,543 shares of company stock valued at $1,315,659 in the last 90 days. Corporate insiders own 1.07% of the company’s stock.

Trending Headlines about International Flavors & Fragrances Here are the key news stories impacting International Flavors & Fragrances this week:

Positive Sentiment: IFF is trading above its 50-day and 200-day moving averages and near its 52-week high, signaling continued investor momentum even though the latest reports do not identify a new fundamental catalyst. Positive Sentiment: The company authorized a $2.5 billion share-repurchase program, potentially covering up to 12.1% of outstanding shares. The buyback may support earnings per share and suggests management believes the stock is undervalued. Positive Sentiment: Institutional ownership remains high at approximately 96%, while several large investors—including BlackRock, Invesco and Ameriprise—recently increased or initiated positions. IFF also declared a quarterly dividend of $0.40 per share. Neutral Sentiment: CEO Erik Fyrwald is scheduled to participate in a Barclays Global Consumer Conference fireside chat on September 10. Investors may look for updates on strategy, operating performance and capital allocation, but no new guidance has been provided. IFF Barclays conference announcement Negative Sentiment: Zacks Research repeatedly lowered its EPS forecasts and maintained a “Strong Sell” rating. FY2026 EPS was cut to $3.14 from $4.45, FY2027 to $3.71 from $4.81, and FY2028 to $4.31 from $5.21. The revisions indicate expectations for weaker profitability over multiple years. Negative Sentiment: The largest near-term reduction was for Q3 2026 EPS, lowered to $0.67 from $1.14. Estimates for Q4 2026 and each quarter of 2027 were also reduced, raising concerns about sustained earnings pressure and IFF’s elevated valuation. Negative Sentiment: An insider sold 5,718 shares for approximately $476,000 at an average price of $83.19. One transaction is not conclusive, but it provides a modest negative signal for investors monitoring insider confidence. IFF insider sale report Negative Sentiment: IFF’s latest reported quarter missed analyst expectations, with EPS of $0.82 versus $1.07 expected and revenue of $1.95 billion versus $2.62 billion expected, reinforcing concerns behind the estimate cuts. International Flavors & Fragrances Price Performance International Flavors & Fragrances stock opened at $84.31 on Monday. The stock has a market capitalization of $21.51 billion, a P/E ratio of 77.35, a P/E/G ratio of 3.12 and a beta of 0.93. The company’s fifty day moving average price is $79.56 and its 200 day moving average price is $76.34. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.72 and a current ratio of 2.06. International Flavors & Fragrances Inc. has a 1 year low of $59.14 and a 1 year high of $89.32.

International Flavors & Fragrances (NYSE:IFF – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The specialty chemicals company reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.25). International Flavors & Fragrances had a net margin of 2.78% and a return on equity of 7.11%. The company had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $2.62 billion. During the same period in the previous year, the business earned $1.15 earnings per share. The business’s revenue for the quarter was up 1.8% on a year-over-year basis. As a group, equities research analysts anticipate that International Flavors & Fragrances Inc. will post 3.08 earnings per share for the current fiscal year.

International Flavors & Fragrances Dividend Announcement The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 9th. Shareholders of record on Friday, September 18th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.9%. The ex-dividend date is Friday, September 18th. International Flavors & Fragrances’s payout ratio is 146.79%.

International Flavors & Fragrances declared that its board has authorized a stock buyback program on Tuesday, August 4th that allows the company to repurchase $2.50 billion in outstanding shares. This repurchase authorization allows the specialty chemicals company to repurchase up to 12.1% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

International Flavors & Fragrances Company Profile (Free Report)

International Flavors & Fragrances Inc (NYSE:IFF) is a global leader in the creation and production of flavors, fragrances, cosmetic actives and nutritional lipids. The company develops taste and scent solutions for a wide array of end markets including food and beverage, personal care, household goods and pharmaceutical products. Its portfolio spans natural and nature-identical flavors, fine fragrances, functional ingredients for skin and hair care, and specialty oils that enhance nutritional value and sensory appeal.

IFF’s research and development network comprises innovation centers in North America, Europe, Asia-Pacific and Latin America, where multidisciplinary teams collaborate on aroma chemistry, sensory science and biotechnology.

Featured Articles Five stocks we like better than International Flavors & Fragrances VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over Want to see what other hedge funds are holding IFF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for International Flavors & Fragrances Inc. (NYSE:IFF – Free Report).

Receive News & Ratings for International Flavors & Fragrances Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Flavors & Fragrances and related companies with MarketBeat.com's FREE daily email newsletter.

Bank of Nova Scotia acquired a new stake in Stifel Financial Corporation (NYSE:SF – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 519,811 shares of the financial services provider’s stock, valued at approximately $36,267,000. Bank of Nova Scotia owned 0.34% of Stifel Financial at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. BlackRock Inc. bought a new stake in Stifel Financial during the 2nd quarter valued at $1,031,197,000. AQR Capital Management LLC grew its holdings in Stifel Financial by 94.8% during the 4th quarter. AQR Capital Management LLC now owns 2,893,850 shares of the financial services provider’s stock worth $362,368,000 after acquiring an additional 1,408,347 shares in the last quarter. Norges Bank bought a new position in Stifel Financial during the 4th quarter worth about $172,446,000. Bank of New York Mellon Corp purchased a new position in Stifel Financial during the 2nd quarter valued at about $93,235,000. Finally, Algebris UK Ltd. bought a new stake in shares of Stifel Financial in the 2nd quarter valued at about $70,086,000. 82.01% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Stifel Financial In other news, Director Maryam S. Brown sold 4,700 shares of the stock in a transaction on Thursday, July 23rd. The shares were sold at an average price of $79.20, for a total value of $372,240.00. Following the sale, the director owned 5,729 shares in the company, valued at $453,736.80. This represents a 45.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 3.36% of the stock is owned by company insiders.

Stifel Financial Stock Down 0.0% Shares of SF stock opened at $80.95 on Monday. The stock’s 50-day simple moving average is $78.20 and its 200-day simple moving average is $76.43. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.83 and a current ratio of 0.88. The firm has a market capitalization of $12.22 billion, a PE ratio of 14.49 and a beta of 0.99. Stifel Financial Corporation has a fifty-two week low of $67.81 and a fifty-two week high of $89.83. Stifel Financial (NYSE:SF – Get Free Report) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $1.42 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.09. The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.42 billion. Stifel Financial had a return on equity of 19.22% and a net margin of 16.11%.The company’s revenue was up 13.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.71 earnings per share. Equities analysts expect that Stifel Financial Corporation will post 6.36 earnings per share for the current year.

Stifel Financial Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Tuesday, September 1st. Stifel Financial’s dividend payout ratio is 24.33%.

Analyst Ratings Changes A number of equities analysts have recently issued reports on SF shares. UBS Group set a $90.00 price objective on shares of Stifel Financial in a research note on Thursday, July 23rd. Weiss Ratings reissued a “buy (b-)” rating on shares of Stifel Financial in a research note on Friday, May 29th. Wall Street Zen cut Stifel Financial from a “buy” rating to a “hold” rating in a research report on Sunday, August 9th. JPMorgan Chase & Co. lifted their price target on Stifel Financial from $80.00 to $86.00 and gave the company a “neutral” rating in a report on Thursday, July 23rd. Finally, Zacks Research raised Stifel Financial from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 20th. Five equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $91.90.

Get Our Latest Stock Analysis on SF

(Free Report)

Stifel Financial Corp. is a diversified financial services holding company headquartered in St. Louis, Missouri. Founded in 1890, the firm has grown into a full‐service brokerage and investment banking organization serving individual investors, corporations and institutions. Through its principal subsidiary, Stifel, Nicolaus & Company, Incorporated, the company delivers a broad array of financial products and services backed by research‐driven insights.

The firm’s main business activities are organized into two core segments: Private Client Group and Institutional Group.

Read More Five stocks we like better than Stifel Financial VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over Want to see what other hedge funds are holding SF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stifel Financial Corporation (NYSE:SF – Free Report).

Receive News & Ratings for Stifel Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stifel Financial and related companies with MarketBeat.com's FREE daily email newsletter.

Curaleaf's self-serving portrayal of our business is an attempt to acquire Aurora's world class EU-GMP manufacturing facilities and global medical cannabis footprint at the lowest price possible Aurora's international strategy is working; net revenue is up 17%YOY Contrary to Curaleaf's inaccurate statements, Aurora's high margin German business is growing and continues to be a key driver of Aurora's international growth strategy Shareholders are advised to TAKE NO ACTION pending formal recommendation from the Board and Special Committee. Offer remains open for at least 105 days from the launch of the Hostile Bid Questions about the Offer or would like to stay informed? Please contact Kingsdale Advisors toll-free at 1-800-749-9052 within North America, call or text 416-623-4172 or at [email protected] , /PRNewswire/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the leading Canadian-based global medical cannabis company, today cautioned shareholders that Curaleaf Holdings, Inc.'s ("Curaleaf") (TSX: CURA) (OTCQX: CURLF) announcement of an unsolicited take-over bid ( "Hostile Bid") appears to contain inaccurate statements about Aurora's business and should be viewed skeptically.

Aurora's Board of Directors, together with a newly formed Special Committee of independent directors, is reviewing Curaleaf's proposal in consultation with financial and legal advisors to determine the course of action that best serves the interests of the Company and its shareholders.

Shareholders are advised to TAKE NO ACTION with respect to the Curaleaf offer at this time.

"Curaleaf's timing and public comments appear to be a transparent attempt to pressure Aurora shareholders into making a short-term decision for the benefit of Curaleaf shareholders," said Miguel Martin, Executive Chairman and CEO of Aurora. "Curaleaf's interest underscores the value that Aurora has created. They are trying to acquire our world-class EU-GMP global infrastructure at the lowest possible price, depriving our shareholders of the long-term value our strategy is built to deliver."

"This opportunistic Hostile Bid comes as Aurora's multi-year transformation into a high-margin, global medical cannabis leader is yielding positive results. With three consecutive years of positive adjusted EBITDA1, accelerating international sales and our recent expansion into the critical UK market, Aurora is reaching a pivotal inflection point," Mr. Martin added.

"The Company's Special Committee of the Board has not yet made a formal recommendation regarding the Offer; Aurora will not let inaccurate statements about the Company stand uncorrected while the review is underway. The Special Committee and Board are focused on protecting shareholder investment and ensuring full value is realized" Mr. Martin concluded.

Setting the record straight

Curaleaf has made several public claims regarding Aurora's operational and market performance that do not accurately or fully reflect the Company's business model or actual financial results:

Response and Engagement to the Offer: As Curaleaf acknowledged in its Hostile Bid circular, Aurora has had several discussions with Curaleaf since June 2026, most recently on August 12. Discussions included Aurora's Lead Independent Director and the Executive Chairman and CEO. Curaleaf's public statements appear to de-emphasize these repeated engagements. International Medical Market Performance: German Market Remains a Major Driver of International Growth: Germany is a key driver of Aurora's 17% year-over-year international net revenue growth in fiscal Q1'27, compared to the prior year quarter, as the Company continues to grow its medical cannabis business in that market. Curaleaf claims that regulatory changes to German medical reimbursement are contributing to a major challenge for Aurora. This is incorrect: the reimbursement market segment accounted for less than 10 percent of Aurora's total German volume prior to these changes. UK Market Position and Growth Opportunities: Aurora is gaining share in the UK, where patients have consistently preferred its high-quality products. On August 19, 2026, Aurora strengthened its position by acquiring Internode Pharma Limited and HAP Pharma Limited, expanding direct distribution in Europe's fastest-growing medical market. Aurora continues to be a market leader in Poland Aurora continues to hold the #1 market share position by revenue in Poland. Increases in annual import limits and a loyal patient base strengthen Aurora's growth outlook in this key, highly-regulated market. Financial Strength Refutes Curaleaf's Claims: Aurora's recent financial performance demonstrates a stronger, more focused business than Curaleaf's characterization suggests. Aurora delivered record global medical cannabis revenue and adjusted EBITDA1 results in FY2026. Momentum continues, with YOY growth in international net revenue and industry leading adjusted gross margins before FV adjustments1 These strong results reflect Aurora's strategy of prioritizing global medical cannabis growth, including exiting the lower-margin Plant Propagation and Canadian Consumer businesses. Curaleaf's Cultivation Claims Ignore the Strength of Aurora's Facilities Curaleaf's comments on Aurora's cultivation methods and output per square foot are inaccurate and outdated, and do not reflect the strength of Aurora's cultivation facilities. Aurora has built specialized expertise in manufacturing facilities that cannot be easily replicated. Through years of operating large-scale EU-GMP-certified facilities, Aurora has developed the scientific, cultivation, regulatory and operational capabilities that support its global medical cannabis strategy. Aurora is proactively expanding capacity to support international growth and ensure consistent supply as regulatory standards tighten and patient demand grows. Over the past five years, Aurora has increased its EU-GMP production capacity by more than 40% and continues to invest further, including through capacity added in the Safari Flower Company transaction. Aurora Shareholders are advised to TAKE NO ACTION with respect to the Curaleaf offer at this time.

Aurora shareholders with questions about the Offer or who would like to stay informed may contact Aurora's strategic advisor and information agent:

Kingsdale Advisors

Toll-Free (within North America): 1-800-749-9052 Call or Text: 416-623-4172 Email: [email protected] ____________________________     

1 Note this press release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. These measures are not standardized financial measures under the financial reporting framework used to prepare Aurora's financial statements and might not be comparable to similar financial measures disclosed by other issuers. These terms and the reconciliations to the most comparable GAAP measures are defined in the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of the FY27 Q1 MD&A, filed August 5, 2026, which can be found on Sedar+, EDGAR and Aurora's website.

About Aurora Cannabis

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia, and New Zealand with a portfolio of trusted, leading brands including Aurora®, MedReleaf®, Pedanios®, IndiMed™, San Raf®, and Whistler Medical Marijuana Corporation®. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™. 

Learn more at www.auroramj.com and follow us on X and LinkedIn.

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".

Forward Looking Statements

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities laws ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements and information about Curaleaf's Hostile Bid, timing and any recommendation with respect to the same, statements regarding the Company's strategy, including expected results with respect to its multi-year transformation into a high-margin, global medical cannabis leader, expectations for accelerating international sales, and continued investment in the Company's EU-GMP platform; and statements regarding the creation of long-term value for shareholders

 These forward-looking statements are only predictions. Forward-looking information or statements contained in this news release have been developed based on the Company and its management's good faith assumptions relating to the financial, market, regulatory and other relevant environments that will exist and affect the Company's business and operations in the future. Forward-looking information and statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management at the date the statements are made including, among other things, assumptions about: development costs remaining consistent with budgets; the ability to manage anticipated and unanticipated costs; access to favorable equity and debt capital markets; the ability to raise sufficient capital to advance the business of the Company; favorable operating and economic conditions; political and regulatory stability; obtaining and maintaining all required licenses and permits; receipt of governmental approvals and permits; sustained labour stability; stability in financial and capital goods markets; favorable production levels and costs from the Company's operations; the pricing of various cannabis products; the level of demand for cannabis products; the availability of third-party service providers and other inputs for the Company's operations; and the Company's ability to conduct operations in a safe, efficient, and effective manner. The Company does not give any assurance that the assumptions on which forward-looking information or statements are based will prove to be correct, or that the Company's business or operations will not be affected in any material manner by these or other factors not foreseen or foreseeable by the Company or management or beyond the Company's control. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the availability of additional capital to complete construction projects and facilities improvements, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion to revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crisis, and other risks as set out under the heading "Risk Factors" in the Company's annual information form dated June 10, 2026 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

Non-GAAP Measures1

This news release contains reference to certain financial performance measures that are not recognized or defined under IFRS (termed "Non-GAAP Measures"). As a result, this data may not be comparable to data presented by other licensed producers of cannabis and cannabis companies. Non-GAAP Measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company's operating results, underlying performance and prospects in a manner similar to Aurora's management. Accordingly, these non-GAAP Measures are intended to provide additional information and to assist management and investors in assessing financial performance and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. The information included under the heading "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" in the FY27 Q1 MD&A is incorporated by reference into this news release. The MD&A is available on the Company's issuer profiles on SEDAR+ at www.sedarplus.com and on the U.S. Securities and Exchange Commission's (the "SEC") EDGAR website at www.sec.gov.

SOURCE Aurora Cannabis Inc.

For Immediate ReleaseChicago, IL – August 24, 2026 – Today, Zacks Equity Comfort Systems USA (FIX - Free Report) , Carrier Global Corp. (CARR - Free Report) and SPX Technologies, Inc. (SPXC - Free Report)

Industry: HVAC

Link: https://www.zacks.com/commentary/2978143/3-air-conditioner-heating-stocks-to-buy-as-hvac-demand-grows

The Zacks Building Products - Air Conditioner & Heating industry continues to benefit from several favorable trends in 2026. Rapid data center development is driving demand for specialized and energy-efficient cooling systems, while electrification and tighter efficiency standards are supporting heat pumps and other advanced HVAC solutions. Rising adoption of smart controls and connected systems, along with steady service and aftermarket demand, provides further support.

On the downside, weakness in single-family construction and cautious consumer spending continue to limit residential HVAC demand, increasing dependence on replacement activity. Tariffs, commodity and freight inflation also create cost pressures, while investments in new manufacturing capacity can weigh on margins through start-up costs and lower initial utilization. Despite these challenges, companies such as Comfort Systems USA, Carrier Global Corp. and SPX Technologies, Inc. are also expanding their opportunities through acquisitions, digital capabilities and service-oriented business models, while growing demand for indoor air quality and mission-critical cooling supports recurring revenue streams.

Industry DescriptionThe Zacks Building Products - Air Conditioner & Heating industry comprises designers, manufacturers, and marketers of a broad range of products for heating, ventilation, air conditioning, and refrigeration markets. The products include rooftop units, chillers, air-handling units, condensing units and coils. 

The industry players also supply thermostats, insulation materials, refrigerants, grills, registers, sheet metal, tools, concrete pads, tape and adhesives. Air conditioning and heating equipment are sold in residential replacement, commercial and industrial HVAC (heating, ventilation and air conditioning), as well as residential new construction markets.

4 Trends Shaping the Future of the Air Conditioner & Heating IndustryData Center Boom Fuels Commercial HVAC Demand: Rapid investment in AI, cloud computing and hyperscale data centers is emerging as a major growth driver for the U.S. Air Conditioner and Heating industry. These facilities require large, reliable and energy-efficient cooling systems to manage increasingly dense computing workloads. Demand is expanding across air- and water-cooled chillers, custom air handlers, cooling towers, dry and adiabatic cooling systems and related equipment. 

Strong project pipelines are also encouraging manufacturers to expand production capacity and improve throughput. Importantly, hyperscale and colocation projects generally provide greater forward visibility because cooling equipment must be secured well before facilities become operational, supporting a favorable multiyear demand outlook. 

Electrification, Efficiency Upgrades and Smart HVAC Drive Growth: Electrification, tighter efficiency standards and smart-building adoption are supporting U.S. HVAC industry growth in 2026. Demand for electric heat pumps, high-SEER air conditioners and low-GWP refrigerant systems is rising as customers seek lower energy use and compliance with stricter regulations. Federal and state incentives are helping offset upgrade costs, while aging equipment supports resilient replacement demand.

Meanwhile, HVAC systems are becoming more connected through intelligent controls, smart thermostats, humidification systems and actuated valves, improving efficiency, performance and operational visibility. This shift toward higher-value, connected equipment is also expanding service and aftermarket opportunities across residential and commercial markets.

Housing Weakness Limits Residential HVAC Recovery: Residential HVAC demand remains under pressure from persistent weakness in the U.S. housing market. New single-family construction continues to face challenges, while cautious consumer spending is restraining discretionary repair and remodeling activity. A meaningful recovery in residential construction is not expected in 2026, limiting demand for HVAC systems tied to new homes. 

Although earlier channel destocking is fading, underlying demand remains subdued and increasingly reliant on replacement activity rather than new installations. These conditions could keep residential HVAC volumes under pressure and make the segment more vulnerable to housing affordability constraints, elevated borrowing costs and continued consumer caution.

Tariffs, Inflation and Capacity Costs Pressure Margins: Cost pressures remain a key challenge for the U.S. Air Conditioner and Heating industry in 2026. Tariffs are raising costs for certain materials and components, while commodity, freight and other inflationary pressures add uncertainty to the price-cost equation. Pricing actions can offset some of these pressures, but tariff-related price increases do not necessarily translate into higher margins.

At the same time, manufacturers are rapidly expanding capacity to meet strong commercial and data center demand. New facilities and production lines can initially generate start-up costs, lower utilization and operating inefficiencies. Higher utilization, sourcing improvements and productivity gains will therefore be important for margin improvement.

Zacks Industry Rank Indicates Bright ProspectsThe Zacks Building Products - Air Conditioner & Heating industry is a nine-stock group within the broader Zacks Construction sector. The industry currently carries a Zacks Industry Rank #32, which places it in the top 13% of more than 250 Zacks industries. 

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates optimistic near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

The industry’s positioning in the top 50% of the Zacks-ranked industries is a result of a higher earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are gradually gaining confidence in this group’s earnings growth potential. Since June 2026, the industry’s earnings estimates for 2026 and 2027 have increased to $5.11 per share (from $4.91) and $5.95 per share (from $5.70), respectively.

We highlight a few stocks that investors may consider adding to their portfolios. First, we examine the industry’s shareholder returns and current valuation backdrop.

Industry Outperforms Sector, Lags S&P 500The Zacks Air Conditioner & Heating industry has outperformed the broader Zacks Construction sector but lagged the Zacks S&P 500 Composite over the past year.

In the same time frame, the industry has gained 16.7% compared with the broader sector’s 6.5% rise. Meanwhile, the Zacks S&P 500 Composite has gained 23.4% during the period.

Industry's Current ValuationOn the basis of the forward 12-month price to earnings, which is a commonly used multiple for valuing Air Conditioner and Heating stocks, the industry is currently trading at 23.87X compared with the S&P 500’s 20.55X and the sector’s 19.99X.

Over the past five years, the industry has traded as high as 30.77X, as low as 15.87X and at a median of 23.97X.

3 Air Conditioner and Heating Stocks to Buy NowBelow, we have discussed three stocks from the Zacks Air Conditioner & Heating universe with solid growth potential.

Comfort Systems: Based in Houston, TX, the company is a national provider of comprehensive heating, ventilation and air conditioning installation, along with maintenance, repair and replacement services. Comfort Systems is benefiting from strong demand across technology and other industrial markets, supported by continued data center construction and rising needs for complex mechanical and electrical infrastructure. Direct relationships with hyperscalers provide visibility into future projects, while sustained customer demand supports further expansion of its modular operations.  

The company is also broadening its modular customer base through opportunities with frontier labs and colocation providers.  Strong institutional demand, disciplined project selection and skilled tradespeople further support execution. Meanwhile, the growing installed base of data centers creates a longer-term opportunity to expand recurring service and maintenance work.

 Comfort Systems currently carries a Zacks Rank #1 (Strong Buy). The stock has gained 142.6% over the past year. FIX has seen an upward estimate revision for 2026 earnings per share (EPS) to $45.86 from $43.05 over the past 30 days. The estimated figure indicates 58.8% year-over-year growth in 2026. Comfort Systems surpassed earnings estimates in all the trailing four quarters, with the average surprise being 34.6%. Again, Comfort Systems’ trailing 12-month return on equity of 53.6% is better than its peer group average of 16.9%. It has a VGM Score of B. You can see the complete list of today’s Zacks #1 Rank stocks here.

SPX Technologies: Headquartered in Charlotte, NC, SPX Technologies supplies infrastructure equipment for global HVAC and detection and measurement markets. SPX Technologies is benefiting from robust demand for data center cooling solutions, supported by hyperscaler, colocation and neocloud customers. Capacity expansions, improved production flow, lean initiatives and higher throughput are strengthening its ability to meet this demand.  

The Neptronic acquisition adds another growth avenue by broadening SPX’s HVAC portfolio with intelligent controls, electric heating, humidification and actuated valves, while expanding its addressable markets.  Strong customer relationships and global distribution channels provide cross-selling opportunities. Meanwhile, healthy project activity, innovation and synergy initiatives in Detection & Measurement, along with an active acquisition pipeline, should support further growth.

SPX Technologies currently carries a Zacks Rank #2. The stock has gained 7.4% over the past year. SPXC has seen an upward estimate revision for 2026 EPS to $8.41 from $8.06 over the past 30 days. The estimated figure indicates 24.4% year-over-year growth in 2026. SPXC surpassed earnings estimates in all the trailing four quarters, with the average surprise being 8.6%. Again, SPXC’s trailing 12-month return on equity is 16.5%.

Carrier: Headquartered in Palm Beach Gardens, FL, Carrier provides intelligent climate and energy solutions worldwide. Carrier has been benefiting from robust commercial HVAC demand, particularly from data centers, supported by growing hyperscaler and colocation investments and capacity expansion. Growing adoption of liquid cooling provides another opportunity as AI infrastructure becomes more power intensive. 

The recovery in residential and light commercial HVAC, supported by replacement demand and improving channel conditions, adds momentum. In Europe, heat-pump adoption, supportive subsidies, high natural-gas prices and new product launches remain favorable. Carrier is also benefiting from expanding aftermarket opportunities, while the 75F acquisition strengthens its intelligent-building, AI-enabled controls and systems-integration capabilities, broadening its addressable markets.

Carrier currently carries a Zacks Rank #2 (Buy). The stock has lost 11.2% over the past year. Carrier has seen an upward estimate revision for 2026 EPS to $2.85 from $2.79 over the past 30 days. The estimated figure indicates 10% year-over-year growth in 2026. Carrier surpassed earnings estimates in three of the trailing four quarters and missed on the other, with the average surprise being 8.5%.

Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.

Today you can access their live picks without cost or obligation.

See Stocks Free >>

Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch/

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance  for information about the performance numbers displayed in this press release.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

AI compute is a power problem before it is a chip problem. Hyperscaler capex keeps climbing, PJM capacity prices keep clearing higher, and utilities keep telling the same story: firm, clean, always-on megawatts are the scarce resource. Three US-listed names sit at the pointy end of that thesis, one for each layer of the nuclear stack. Constellation runs the largest US reactor fleet. Talen owns the merchant baseload assets closest to the data center demand curve in PJM. Uranium Energy supplies the fuel from domestic soil.

All three have moved on real catalysts this year, and all three are pricing in different pieces of the same trade.

Constellation Energy: Largest US Nuclear Operator, Raised Guidance Constellation Energy (NASDAQ:CEG | CEG Price Prediction) is trading at $272.88 with a market cap near $96.7 billion and a forward P/E of 23. The Street average target sits at $347.40, with 6 Strong Buy and 14 Buy ratings against 3 Holds. Shares are down 22.41% year to date, compressing the valuation on a company that just raised guidance.

Q2 adjusted EPS of $2.55 beat the $2.3284 estimate by 9.52%, with revenue of $7.504 billion, up 23% year over year. Nuclear output hit 44,160 GWh at a 93% capacity factor. Management lifted full-year 2026 adjusted EPS guidance to $11.50 to $12.50 from $11.00 to $12.00 and reiterated a base EPS growth projection of 20% or more through 2029.

The bull case is contract-backed demand. Constellation has signed 920 MW of 15 to 20-year nuclear PPAs with investment-grade customers, is advancing the Crane Clean Energy Center restart targeting 2027, and filed license renewals for Ginna and Nine Mile Point Unit 1 out to 2049. CEO Joe Dominguez framed the quarter as "strengthening the nation’s energy infrastructure and helping meet growing demand for reliable power." Management said hyperscaler spending for 2026 was tracking "nearly 75% higher than last year and continue to be revised upward." A $5.0 billion buyback authorization with roughly $2.8 billion remaining gives management a lever if the stock stays discounted.

Risk: PJM regulatory rules for large-load interconnection and Reliability Backstop Procurement are still being written, the Illinois ZEC program ends in May 2027, and planned nuclear refueling outage days ran 86 versus 41 a year ago. Calpine integration risk is real given the scale of the January 2026 close.

Talen Energy: PJM Capacity Tailwind and Four-Gigawatt Data Center Pipeline Talen Energy (NASDAQ:TLN) trades at $314.46, down 16.68% over the past month after a messy GAAP print. Market cap sits at $15.07 billion, forward P/E at 13, and the Street’s average target is $465.19 with 6 Strong Buy and 8 Buy ratings.

Q2 headline EPS of -$2.00 missed the $3.3912 estimate, dragged by $211 million in unrealized commodity derivative losses and interest expense that jumped to $214 million from $62 million on $4 billion in new senior unsecured notes funding Cornerstone. Adjusted EBITDA came in at $374 million versus $90 million, versus a year ago, and generation totaled 14.1 TWh. Generation nearly doubled to over 10 GW in the 2028/2029 PJM Base Residual Auction at $325/MWd.

Talen cleared more than 10 GW in the 2028/2029 PJM Base Residual Auction at $2.025 billion to $2.225 billion, raised 2026 adjusted EBITDA guidance to $40 per share, and lifted 2028 base-case free cash flow to 4 GW of land development and data center contracting options. Management flagged approximately 4 GW of data center pipeline options, with the AWS ramp expected to push long-term contracted margin from "leveraging our advantaged portfolio of assets, building our development pipeline of powered land and new capacity all of which allows us to enter into long-term contracts with large loads.". CEO Mac McFarland noted that 30% of 2028 generation is hedged.

Risk: only below 3.5x target of 2028 generation is contracted, leaving Talen exposed to a commodity reversal, and net leverage runs against a target below 3.5x as it digests Cornerstone.

Uranium Energy: Domestic Fuel, Zero Debt, Policy Tailwind Uranium Energy (NYSE:UEC) sits at 31.14% over the past month, up 14.44% on August 21 alone and $6.26 billion. Market cap is roughly $6.26B, and the analyst consensus target implies meaningful upside. This is the upstream exposure: a pure-play US producer with the largest domestic uranium resource base.

Fiscal Q3 produced total cost per pound of $54.61 at a 200,000 pounds at $101 per pound versus a spot average of $80.76, with no revenue recognized as management held inventory. In fiscal Q2, UEC sold 1,456,000 pounds valued at $127 million. Inventory sits at $488 million in cash, backed by $794 million in liquid assets, Burke Hollow began production on April 8, 2026, and zero debt.

The catalysts are strategic. "the largest greenfield ISR uranium project to come into production in more than a decade.", described by management as "the DOE’s ‘Nuclear Dominance: 3 by 33’ initiative, which underscores the urgency of rebuilding a secure, domestic fuel supply chain." CEO Amir Adnani tied the story to Washington policy: Fluor Corporation UEC is also advancing US-based uranium refining and conversion with delayed regulatory approvals and higher Wyoming state taxes.

Risk: single-commodity exposure, no revenue this quarter, and rising per-pound costs. If uranium prices stall, the unhedged strategy cuts both ways.

Different assets, one thesis. Constellation offers scale and contract visibility, Talen offers merchant torque to PJM prices, and UEC offers the fuel. September’s setup gives investors three distinct angles on the AI power buildout to evaluate (we mapped five ways to play the nuclear restart, utilities and fuel included, in a free report here).

Contact [email protected] for any questions or corrections.

Deutsche Bank AG acquired a new stake in Glaukos Corporation (NYSE:GKOS – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 61,957 shares of the medical instruments supplier’s stock, valued at approximately $8,659,000. Deutsche Bank AG owned about 0.11% of Glaukos at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. Los Angeles Capital Management LLC bought a new position in shares of Glaukos during the fourth quarter worth approximately $28,000. Larson Financial Group LLC lifted its position in Glaukos by 62.0% during the fourth quarter. Larson Financial Group LLC now owns 345 shares of the medical instruments supplier’s stock worth $39,000 after purchasing an additional 132 shares during the period. Parallel Advisors LLC lifted its position in Glaukos by 159.2% during the first quarter. Parallel Advisors LLC now owns 368 shares of the medical instruments supplier’s stock worth $40,000 after purchasing an additional 226 shares during the period. Farther Finance Advisors LLC grew its stake in Glaukos by 111.4% during the fourth quarter. Farther Finance Advisors LLC now owns 408 shares of the medical instruments supplier’s stock worth $46,000 after buying an additional 215 shares in the last quarter. Finally, CWM LLC grew its stake in Glaukos by 25.2% during the fourth quarter. CWM LLC now owns 710 shares of the medical instruments supplier’s stock worth $80,000 after buying an additional 143 shares in the last quarter. Institutional investors own 99.04% of the company’s stock.

Glaukos Trading Up 0.4% GKOS opened at $185.66 on Monday. The company’s 50 day moving average is $157.38 and its 200-day moving average is $131.72. Glaukos Corporation has a 1-year low of $73.16 and a 1-year high of $191.62. The company has a current ratio of 5.04, a quick ratio of 4.46 and a debt-to-equity ratio of 0.10. The company has a market cap of $10.95 billion, a P/E ratio of -57.13 and a beta of 0.78.

Glaukos (NYSE:GKOS – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The medical instruments supplier reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.07. The company had revenue of $185.61 million for the quarter, compared to analyst estimates of $150.93 million. Glaukos had a negative net margin of 30.68% and a negative return on equity of 6.37%. The firm’s revenue was up 49.6% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.24) EPS. Equities research analysts predict that Glaukos Corporation will post -0.32 earnings per share for the current fiscal year. Analyst Ratings Changes Several brokerages have recently commented on GKOS. Stifel Nicolaus boosted their target price on shares of Glaukos from $175.00 to $190.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. Needham & Company LLC increased their price target on shares of Glaukos from $150.00 to $201.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Piper Sandler reissued an “overweight” rating and issued a $195.00 price objective (up from $165.00) on shares of Glaukos in a research note on Thursday, July 30th. JPMorgan Chase & Co. boosted their price objective on shares of Glaukos from $120.00 to $140.00 and gave the company an “overweight” rating in a research report on Thursday, April 30th. Finally, UBS Group began coverage on Glaukos in a research note on Tuesday, July 28th. They set a “neutral” rating and a $150.00 target price for the company. Twelve analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $178.08.

View Our Latest Stock Analysis on GKOS

Insider Activity at Glaukos In other news, COO Joseph E. Gilliam sold 60,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $179.74, for a total value of $10,784,400.00. Following the completion of the transaction, the chief operating officer directly owned 72,588 shares in the company, valued at approximately $13,046,967.12. This represents a 45.25% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gilbert H. Kliman sold 2,500 shares of the stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $190.00, for a total value of $475,000.00. Following the completion of the transaction, the director owned 37,406 shares of the company’s stock, valued at $7,107,140. The trade was a 6.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 113,025 shares of company stock worth $19,600,006. Corporate insiders own 5.90% of the company’s stock.

Glaukos News Roundup Here are the key news stories impacting Glaukos this week:

Positive Sentiment: BTIG Research raised its price target to $202 from $193 and maintained a “Buy” rating, implying additional upside from the referenced share price. The move reinforces bullish sentiment among analysts. BTIG price target report Positive Sentiment: Zacks Research lifted its FY2026 EPS forecast to a loss of $0.43 from a loss of $0.65, its Q3 2026 estimate to a loss of $0.13 from $0.16, and its Q4 estimate to positive $0.03 from a loss of $0.02. The revisions suggest improving near-term earnings trends. Positive Sentiment: Zacks also raised its FY2027 EPS estimate to $0.45 from $0.38 and its FY2028 forecast to $1.70 from $1.56. Several later-quarter estimates were increased, pointing to expectations that Glaukos will become increasingly profitable as its products scale. Positive Sentiment: Momentum in the iDose TR glaucoma implant and the Epioxa launch is reportedly driving record growth, higher 2026 guidance and expansion of Glaukos’ ophthalmology platform. Zacks growth outlook article Neutral Sentiment: Glaukos recently reported revenue of $185.6 million, up 49.6% year over year, while its $0.14 quarterly loss was narrower than expected. However, the company remains unprofitable, and its current-year consensus EPS forecast is still a loss of $0.35. Negative Sentiment: Director Gilbert H. Kliman sold 2,500 shares for approximately $475,000 at an average price of $190, reducing his direct ownership by 6.26%. He retained 37,406 shares, so the transaction is a modest negative signal rather than a major change in insider alignment. SEC insider selling filing Glaukos Company Profile (Free Report)

Glaukos Corporation is a medical technology company specializing in the development, manufacturing and commercialization of innovative therapies for patients with glaucoma and other chronic eye diseases. The company’s core offerings focus on micro-invasive glaucoma surgery (MIGS), designed to reduce intraocular pressure and manage glaucoma more safely and effectively than traditional surgical approaches. Glaukos’s flagship products include the iStent, iStent inject and iStent infinite trabecular micro-bypass stents, which are implanted during cataract surgery to improve aqueous outflow and help control eye pressure.

Beyond its MIGS portfolio, Glaukos has expanded into sustained drug-delivery solutions.

See Also Five stocks we like better than Glaukos VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over

Receive News & Ratings for Glaukos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glaukos and related companies with MarketBeat.com's FREE daily email newsletter.

BlackRock Inc. purchased a new stake in shares of AeroVironment, Inc. (NASDAQ:AVAV – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 3,480,740 shares of the aerospace company’s stock, valued at approximately $574,566,000. BlackRock Inc. owned approximately 6.88% of AeroVironment at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of AVAV. Norges Bank acquired a new position in AeroVironment during the fourth quarter worth $94,655,000. Swedbank AB raised its holdings in AeroVironment by 22,773.4% during the fourth quarter. Swedbank AB now owns 261,214 shares of the aerospace company’s stock valued at $63,185,000 after buying an additional 260,072 shares in the last quarter. Marshall Wace LLP raised its holdings in AeroVironment by 4,770.1% during the fourth quarter. Marshall Wace LLP now owns 260,207 shares of the aerospace company’s stock valued at $62,941,000 after buying an additional 254,864 shares in the last quarter. Heard Capital LLC lifted its position in shares of AeroVironment by 48.4% in the fourth quarter. Heard Capital LLC now owns 722,150 shares of the aerospace company’s stock worth $174,681,000 after buying an additional 235,685 shares during the last quarter. Finally, Franklin Resources Inc. lifted its position in shares of AeroVironment by 3,880.9% in the third quarter. Franklin Resources Inc. now owns 206,607 shares of the aerospace company’s stock worth $65,058,000 after buying an additional 201,417 shares during the last quarter. Institutional investors and hedge funds own 86.38% of the company’s stock.

Wall Street Analysts Forecast Growth A number of research analysts have recently commented on AVAV shares. Citizens Jmp lowered their price objective on AeroVironment from $350.00 to $230.00 and set a “market outperform” rating on the stock in a report on Friday, July 10th. KeyCorp restated an “overweight” rating on shares of AeroVironment in a report on Tuesday, July 28th. Citigroup reaffirmed a “market outperform” rating on shares of AeroVironment in a research report on Tuesday, July 28th. Jefferies Financial Group decreased their target price on AeroVironment from $305.00 to $229.00 and set a “buy” rating for the company in a research report on Wednesday, July 1st. Finally, Wolfe Research downgraded AeroVironment to a “buy” rating in a report on Tuesday, June 30th. Two analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $266.68.

View Our Latest Stock Analysis on AeroVironment Insider Activity at AeroVironment In other AeroVironment news, Director Stephen F. Page sold 250 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $191.98, for a total value of $47,995.00. Following the sale, the director owned 48,503 shares of the company’s stock, valued at $9,311,605.94. This trade represents a 0.51% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Brian Charles Shackley sold 205 shares of AeroVironment stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $201.86, for a total value of $41,381.30. Following the completion of the transaction, the chief accounting officer directly owned 7,888 shares in the company, valued at approximately $1,592,271.68. This represents a 2.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 705 shares of company stock valued at $132,979. 0.79% of the stock is owned by corporate insiders.

Key Headlines Impacting AeroVironment Here are the key news stories impacting AeroVironment this week:

Positive Sentiment: New U.S. drone tariffs could benefit AVAV. President Trump’s August 13 proclamation imposes broad tariffs on foreign drone imports, potentially steering demand toward U.S. manufacturers such as AeroVironment and supporting domestic pricing, production and market share. Trump’s New Drone Tariffs Give AeroVironment, Kratos and Red Cat a Policy Tailwind Positive Sentiment: Greek joint venture expands AeroVironment’s European footprint. AV Eagle, formed with Eyeonix SA, will establish localized production and technology capabilities in Greece after receiving foreign-investment approval. The venture could improve access to European defense programs, strengthen supply-chain resilience and position AVAV to participate in the region’s growing counter-drone market. AeroVironment to Establish Industrial Presence in Greece Through AV Eagle Positive Sentiment: Propulsion investments support longer-term growth. AeroVironment is expanding electric, hybrid and unmanned-aircraft propulsion capabilities, potentially broadening its addressable markets beyond current defense platforms. Clear Street also initiated coverage with a Buy rating, adding to generally favorable analyst sentiment. Can AeroVironment’s Propulsion Capabilities Support Future Growth? Neutral Sentiment: Recent operating momentum remains strong, but valuation is demanding. The latest reported quarter included $641.6 million in revenue, up 133.3% year over year, and EPS of $1.84 versus a $1.47 consensus estimate. However, AVAV remains unprofitable on a trailing basis, trades below its 200-day moving average and carries a high PEG ratio, leaving the stock sensitive to execution and future-growth expectations. Negative Sentiment: Shareholder-law-firm investigations add headline risk. Berger Montague and Grabar Law Office are investigating whether AeroVironment’s board properly disclosed potential competition for U.S. Space Force SCAR program work. The claims are allegations, but any litigation, disclosure findings or related costs could pressure investor confidence. Berger Montague investigates AeroVironment’s board Negative Sentiment: A director’s stock sale is a minor cautionary signal. Director Stephen Page sold 250 shares worth approximately $48,000 under a pre-arranged Rule 10b5-1 plan. Because the sale was small relative to his remaining holdings and scheduled in advance, its direct impact is likely limited. AeroVironment Price Performance AVAV stock opened at $160.22 on Monday. The company has a debt-to-equity ratio of 0.17, a current ratio of 4.30 and a quick ratio of 3.59. AeroVironment, Inc. has a 52-week low of $135.20 and a 52-week high of $417.86. The company has a 50-day moving average of $161.80 and a two-hundred day moving average of $190.00. The stock has a market capitalization of $8.14 billion, a price-to-earnings ratio of -43.54, a price-to-earnings-growth ratio of 5.45 and a beta of 1.41.

AeroVironment (NASDAQ:AVAV – Get Free Report) last issued its quarterly earnings results on Monday, June 29th. The aerospace company reported $1.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.37. The company had revenue of $641.62 million for the quarter, compared to the consensus estimate of $555.97 million. AeroVironment had a positive return on equity of 3.71% and a negative net margin of 9.00%.The firm’s revenue was up 133.3% compared to the same quarter last year. During the same period last year, the business posted $1.61 earnings per share. AeroVironment has set its FY 2027 guidance at 3.020-3.340 EPS. As a group, equities research analysts anticipate that AeroVironment, Inc. will post 3.26 EPS for the current year.

AeroVironment Profile (Free Report)

AeroVironment, Inc (NASDAQ:AVAV) is a technology company specializing in unmanned aerial systems (UAS), tactical missiles and precision loitering munitions, electric vehicle charging and scalable energy systems. Headquartered in Monrovia, California, the company develops solutions for defense, public safety and commercial markets. Their offerings include small UAS for intelligence, surveillance and reconnaissance, as well as advanced weapons systems designed to meet the needs of modern military operations.

The company’s unmanned aerial systems portfolio features platforms such as the Raven, Puma and Switchblade series, which are deployed by the U.S.

Recommended Stories Five stocks we like better than AeroVironment VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over

Receive News & Ratings for AeroVironment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AeroVironment and related companies with MarketBeat.com's FREE daily email newsletter.

Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in shares of AECOM (NYSE:ACM – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 5,497,153 shares of the construction company’s stock, valued at approximately $383,701,000. Barrow Hanley Mewhinney & Strauss LLC owned about 4.28% of AECOM at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Towarzystwo Funduszy Inwestycyjnych PZU SA lifted its stake in shares of AECOM by 86.7% in the fourth quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA now owns 280 shares of the construction company’s stock worth $27,000 after buying an additional 130 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its position in shares of AECOM by 95.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 295 shares of the construction company’s stock valued at $28,000 after acquiring an additional 144 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of AECOM by 189.3% during the second quarter. EverSource Wealth Advisors LLC now owns 298 shares of the construction company’s stock valued at $34,000 after acquiring an additional 195 shares in the last quarter. Intesa Sanpaolo Wealth Management purchased a new position in AECOM in the 4th quarter worth approximately $38,000. Finally, Western Wealth Management LLC purchased a new position in AECOM in the 1st quarter worth approximately $36,000. Hedge funds and other institutional investors own 85.41% of the company’s stock.

Wall Street Analyst Weigh In Several equities analysts recently issued reports on the company. Zacks Research cut AECOM from a “hold” rating to a “strong sell” rating in a research report on Monday, August 10th. Piper Sandler set a $79.00 target price on AECOM in a report on Wednesday, August 12th. Citigroup decreased their price target on AECOM from $97.00 to $84.00 and set a “buy” rating for the company in a research note on Wednesday, August 12th. Wall Street Zen downgraded AECOM from a “buy” rating to a “hold” rating in a report on Monday, July 6th. Finally, Robert W. Baird dropped their price objective on AECOM from $73.00 to $65.00 and set a “neutral” rating on the stock in a research report on Friday, August 14th. Nine investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, AECOM presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.58.

Get Our Latest Research Report on AECOM Insider Activity at AECOM In other news, President Lara Poloni acquired 4,224 shares of the business’s stock in a transaction that occurred on Tuesday, June 16th. The stock was bought at an average price of $70.63 per share, with a total value of $298,341.12. Following the completion of the acquisition, the president directly owned 153,446 shares of the company’s stock, valued at approximately $10,837,890.98. The trade was a 2.83% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.46% of the stock is owned by insiders.

AECOM Stock Up 0.1% Shares of AECOM stock opened at $64.88 on Monday. The company has a market cap of $8.35 billion, a price-to-earnings ratio of 29.76, a price-to-earnings-growth ratio of 4.37 and a beta of 0.93. The company’s 50 day moving average is $69.06 and its 200 day moving average is $79.13. AECOM has a twelve month low of $60.35 and a twelve month high of $135.52. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 1.11.

AECOM (NYSE:ACM – Get Free Report) last posted its earnings results on Monday, August 10th. The construction company reported ($0.50) EPS for the quarter, missing analysts’ consensus estimates of $1.46 by ($1.96). The company had revenue of $3.59 billion during the quarter, compared to the consensus estimate of $2.01 billion. AECOM had a return on equity of 19.72% and a net margin of 1.87%.The company’s revenue for the quarter was down 14.2% on a year-over-year basis. During the same period last year, the firm posted $1.34 EPS. AECOM has set its FY 2026 guidance at 3.950-4.150 EPS. Research analysts anticipate that AECOM will post 3.98 EPS for the current year.

AECOM Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Friday, July 17th. Stockholders of record on Wednesday, July 1st were paid a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Wednesday, July 1st. AECOM’s dividend payout ratio (DPR) is 56.88%.

AECOM Profile (Free Report)

AECOM is a multinational infrastructure consulting firm that provides a broad range of professional technical and management services. Its core offerings include architecture and engineering design, program and construction management, environmental remediation and consulting, and operations and maintenance support. The company works across the full project lifecycle from planning and design through construction and long‑term asset management.

AECOM serves public- and private-sector clients in major built-environment markets, including transportation (roads, bridges, rail, airports), water and wastewater systems, buildings and places, energy and power, and environmental services.

Further Reading Five stocks we like better than AECOM VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over

Receive News & Ratings for AECOM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AECOM and related companies with MarketBeat.com's FREE daily email newsletter.

WILMINGTON, Del., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), is announcing the launch of permexa™ sodium caprate, a high-performance intestinal permeation enhancer designed to support the scalable development and commercialization of oral peptide, biologic and low-permeability drug products, including rapidly expanding GLP-1 agonists and related therapeutic pipelines. 

The launch comes at a time of significant market momentum in oral peptide and biologics development. Pharmaceutical companies continue to invest heavily in oral alternatives to injectable therapies, driven by the potential to improve patient convenience, enhance treatment adherence and unlock new therapeutic opportunities. As a result, pipelines across GLP-1’s, diabetes and weight loss, metabolic disorders, endocrine therapeutics and other peptide-based medicines continue to expand. 

Developers continue to face important challenges as programs move from concept through development and manufacturing, despite growing investment and encouraging clinical progress. Permeability enhancement remains critical for oral drug products, but formulation consistency, process robustness and scalability are increasingly recognized as key barriers to successful commercialization. 

Ashland permexa™ sodium caprate was engineered to help address these challenges by combining established sodium caprate functionality with improved pharmaceutical processing performance. The excipient is designed with an IP-protected process to support more robust tablet manufacturing through improved powder flow, enhanced compressibility and greater formulation consistency, while maintaining the permeability enhancement characteristics required for oral drug delivery applications. The result is a solution intended not only for laboratory success, but also for real-world pharmaceutical development and manufacturing environments where reproducibility, scalability and process robustness are essential. 

The Ashland launch follows strong interest from pharmaceutical developers worldwide. Ahead of the commercial launch, the company recorded engagement with multiple pharmaceutical, biotech and CDMO organizations globally, spanning sampling activities, technical evaluations, pre-launch sales, benchmarking studies and formulation development discussions. Customer feedback has been overwhelmingly positive on the product’s differentiated properties. 

“The rapid growth of oral peptide development is creating demand for excipients that support both biological performance and pharmaceutical manufacturability,” said Alessandra Faccin, senior vice president and general manager, Life Sciences, Ashland. “Permexa™ sodium caprate was engineered to help customers address complex challenges and move more confidently from formulation through commercialization. The level of engagement we have seen prior to launch demonstrates the importance of solutions that support both drug delivery performance and scalable manufacturing.” 

Caroline Cooreman, strategy director, Life Sciences, Ashland, continued, “Consequently, Ashland is not stopping here. We have developed a multi-stage strategy to support the pharmaceutical market with essential excipients for the oral delivery of biologics. We have multiple additional products in the pipeline and recognize important synergies with our vinyl pyrrolidone and derivatives (VP&D) portfolio. We are already actively servicing this market with our established VP&D portfolio, which will be further strengthened by our oral biologics’ portfolio expansion,” she concluded.

For more information about Permexa™ sodium caprate and how the expanded Ashland portfolio of solutions for oral biologics delivery—including product information, technical support and sampling opportunities— interested parties should visit http://ashland.com/permexa  or contact their local Ashland solver. 

FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Ashland has identified some of these forward-looking statements with words such as “anticipates,” “believes,” “expects,” “estimates,” “is likely,” “predicts,” “projects,” “forecasts,” “objectives,” “may,” “will,” “should,” “plans” and “intends” and the negative of these words or other comparable terminology. Ashland may from time to time make forward-looking statements in its Annual Report to Stockholders, quarterly reports and other filings with the Securities and Exchange Commission (“SEC”), news releases and other written and oral communications. These forward-looking statements are based on Ashland’s expectations and assumptions, as of the date such statements are made, regarding Ashland’s future operating performance and financial condition, its strategy as well as the economy and other future events or circumstances.

The risks and uncertainties we face which may cause our actual results to differ materially from the results expressed, projected, or implied in these forward-looking statements include, but are not limited to: Ashland’s aggressive growth goals and the extent to which such goals may be impacted by a failure to optimize our tangible and intangible assets, a failure to identify and integrate acquisition targets, any unexpected costs and liabilities associated with such acquisitions, and goodwill impairment; business disruptions stemming from natural, operational, and other catastrophic events, including disruptions to supply and logistics functions, manufacturing delays, and information technology system and network failures; climate change and related resource impacts; changes in consumer preferences and a reduction in demand for Ashland’s products; risks inherent in operating a global business, including tariffs and other trade policies, geopolitical instability and armed conflict, and challenges associated with hiring and managing a diverse workforce across countries with differing laws, regulations, and cultural practices; economic downturns and disruptions in the financial markets; Ashland’s substantial indebtedness, including the possibility that such indebtedness and related restrictive covenants may adversely affect our future cash flows, limit our ability to repay debt and obtain future financing, place Ashland at a competitive disadvantage, and make us more vulnerable to interest rate increases; our ability to develop and market new products and remain competitive in the markets in which we operate; our ability to pass increases in the costs of energy and raw materials to customers and to fulfill our contractual requirements with customers and vendors; downward pressures on prices and margins; the ability to attract and retain key employees and to provide for effective succession planning; cybersecurity risks, including disruptions to or failures in Ashland’s information technology systems and networks, malicious cyberattacks, and the inadvertent or accidental disclosure or loss of proprietary or sensitive information; Ashland’s ability to effectively protect and enforce its intellectual property rights; exposure to products liability claims; risks related to compliance with environmental, health, and safety regulations, including the potential for costly litigation, remediation, and settlement actions; exposure to pending and threatened asbestos-related litigation; changes in the legal and regulatory landscapes in which we operate; and changes in taxation or adverse tax rulings. These risks and uncertainties also include, but are not limited to, the risk factors set forth in Item 1A. “Risk Factors” of Ashland’s most recent Form 10-K, and in our other periodic reports filed with the SEC. Ashland believes its expectations and assumptions are reasonable, but there can be no assurance that the expectations reflected herein will be achieved. Unless legally required, Ashland undertakes no obligation to update publicly any forward-looking statements made in this presentation whether as a result of new information, future events or otherwise. Information on Ashland’s website is not incorporated into or a part of this presentation.

About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. Approximately 2,900 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit ashland.com and ashland.com/ESG to learn more.

™ Trademark, Ashland or its subsidiaries, registered in various countries.

FOR FURTHER INFORMATION:

Investor Relations:Media Relations:Sandy KlugmanCarolmarie C. Brown+1 (302) 594-7777+1 (302) [email protected]@ashland.com Ashland permexa™ sodium caprate Press_Release_Global_Permexa_Launch_FNL_20260824

Ashland permexa™ sodium caprate Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium cap...

 | Source: Martin Marietta Materials, Inc.

RALEIGH, N.C., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Martin Marietta Materials, Inc. (NYSE: MLM) (Martin Marietta or the Company) today announced the completion of its previously announced combination with Lhoist North America, Inc. (LNA), a subsidiary of Lhoist Group, on August 21, 2026. LNA is a leading producer of high calcium lime, dolomitic lime and industrial mineral products, serving a diverse range of end markets, including domestic steel manufacturing, infrastructure, heavy nonresidential construction and environmental solutions.

Ward Nye, Chair, President and CEO of Martin Marietta, stated, "We are pleased to announce the successful completion of the LNA combination. This transformative transaction advances our SOAR 2030 objectives by expanding our Specialties platform and further enhancing the quality, scale and resilience of our business. With one of the most strategically advantaged limestone positions in North America, comprised of more than 2 billion tons of high-quality reserves, the combination establishes Martin Marietta as the nation's leading producer of limestone products and strengthens our portfolio of essential upstream materials."

Mr. Nye concluded, "We are excited to welcome LNA and its talented employees to Martin Marietta. Together, we have created a uniquely advantaged portfolio of essential materials supported by industry-leading reserves, strategically located assets and differentiated end-market exposure. As the United States continues to invest in infrastructure modernization, domestic manufacturing and industrial growth, we believe Martin Marietta is exceptionally well positioned to create sustainable long-term value for shareholders."

The Company expects to provide updated full-year 2026 revenue and Adjusted EBITDA guidance reflecting the completion of this transaction in connection with the release of its third-quarter financial results.

About Martin Marietta

Martin Marietta, a member of the S&P 500 Index, is an American-based company and a leading supplier of aggregates, lime and limestone products, magnesia-based products and other building materials. Supported by industry-leading reserves and a network of operations spanning 29 states, Canada and The Bahamas, Martin Marietta supplies the essential materials that help build, connect and sustain communities across North America. For more information, visit www.martinmarietta.com or www.magnesiaspecialties.com.

Investor Contact:
Jacklyn Rooker
Vice President, Investor Relations
+1 (919) 510-4736
[email protected]                                                 

MLM-G.

This press release contains forward-looking statements under the federal securities laws, including the Private Securities Litigation Reform Act of 1995. These statements include: the anticipated benefits of the transaction including increased profitability, synergies and advancement of SOAR 2030 priorities, and costs and other anticipated financial impacts of the transaction. These statements involve risks and uncertainties and are based on assumptions that the Company believes are reasonable, but which may differ materially from actual results, including, among others, risks and uncertainties relating to adverse industry conditions, and potential business uncertainty. These statements reflect the Company’s current expectations or forecasts of future events. You can identify these statements because they do not relate only to historical or current facts and may use words such as “guidance”, “anticipate”, “may”, “expect”, “should”, “believe”, “will”, and other words of similar meaning in connection with future events or future performance. Any or all of the Company’s forward-looking statements herein and in other publications may prove to be incorrect.

Statements regarding the LNA combination contain forward-looking statements that are based on current expectations and assumptions and are subject to risks and uncertainties. Actual results may differ materially from those expressed or implied due to various factors including but not limited to: Martin Marietta’s long-term leverage targets, transaction costs, integration challenges, market conditions, and other risks described in the Company’s Securities and Exchange Commission filings. A further list and description of risks, uncertainties and other matters can be found in Martin Marietta’s Annual Report on Form 10-K for the year ended December 31, 2025 and in Martin Marietta’s subsequent reports on Form 10-Q, including the sections thereof captioned “Other Matters” and “Item 1A. Risk Factors”, and in Martin Marietta’s subsequent reports on Form 8-K. Except as required by law, Martin Marietta does not undertake any obligation to publicly update any forward-looking statements whether as a result of new information, future events, changed circumstances or otherwise.

Deutsche Bank AG acquired a new stake in shares of Zurn Elkay Water Solutions Cor (NYSE:ZWS – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 162,382 shares of the company’s stock, valued at approximately $8,205,000. Deutsche Bank AG owned approximately 0.10% of Zurn Elkay Water Solutions Cor at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Simplicity Wealth LLC purchased a new position in Zurn Elkay Water Solutions Cor in the 2nd quarter worth approximately $368,000. Global Retirement Partners LLC purchased a new stake in shares of Zurn Elkay Water Solutions Cor in the second quarter valued at approximately $151,000. Bank of New York Mellon Corp purchased a new stake in shares of Zurn Elkay Water Solutions Cor in the second quarter valued at approximately $55,207,000. State of Wyoming acquired a new stake in shares of Zurn Elkay Water Solutions Cor in the second quarter valued at approximately $264,000. Finally, S&CO Inc. acquired a new stake in shares of Zurn Elkay Water Solutions Cor in the second quarter valued at approximately $404,000. Institutional investors and hedge funds own 83.33% of the company’s stock.

Insider Buying and Selling at Zurn Elkay Water Solutions Cor In other Zurn Elkay Water Solutions Cor news, Director Jacques Donavon Butler purchased 2,016 shares of the stock in a transaction dated Wednesday, August 19th. The stock was acquired at an average cost of $49.60 per share, for a total transaction of $99,993.60. Following the acquisition, the director owned 37,487 shares in the company, valued at $1,859,355.20. This trade represents a 5.68% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.40% of the company’s stock.

Analyst Ratings Changes ZWS has been the topic of a number of analyst reports. Stifel Nicolaus lifted their price objective on Zurn Elkay Water Solutions Cor from $56.00 to $62.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Barclays raised their target price on Zurn Elkay Water Solutions Cor from $59.00 to $61.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Zacks Research upgraded Zurn Elkay Water Solutions Cor from a “hold” rating to a “strong-buy” rating in a report on Friday, July 31st. Weiss Ratings reissued a “buy (b)” rating on shares of Zurn Elkay Water Solutions Cor in a research report on Friday, July 24th. Finally, The Goldman Sachs Group reissued a “neutral” rating and issued a $55.00 price objective on shares of Zurn Elkay Water Solutions Cor in a report on Wednesday, July 29th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Zurn Elkay Water Solutions Cor presently has a consensus rating of “Moderate Buy” and an average price target of $57.22. Get Our Latest Analysis on Zurn Elkay Water Solutions Cor

Zurn Elkay Water Solutions Cor Trading Up 0.2% ZWS opened at $49.10 on Monday. Zurn Elkay Water Solutions Cor has a one year low of $43.06 and a one year high of $55.00. The stock has a market capitalization of $8.14 billion, a PE ratio of 30.31, a P/E/G ratio of 1.85 and a beta of 1.04. The business’s 50 day moving average price is $49.46 and its 200 day moving average price is $48.84. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.13 and a current ratio of 3.05.

Zurn Elkay Water Solutions Cor (NYSE:ZWS – Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.03. The company had revenue of $491.00 million during the quarter, compared to analyst estimates of $483.04 million. Zurn Elkay Water Solutions Cor had a return on equity of 18.01% and a net margin of 15.45%.The firm’s revenue for the quarter was up 10.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.42 earnings per share. As a group, equities research analysts expect that Zurn Elkay Water Solutions Cor will post 1.82 EPS for the current year.

Zurn Elkay Water Solutions Cor Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Thursday, August 20th will be issued a dividend of $0.11 per share. The ex-dividend date is Thursday, August 20th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.9%. Zurn Elkay Water Solutions Cor’s dividend payout ratio is currently 27.16%.

Zurn Elkay Water Solutions Cor Company Profile (Free Report)

Zurn Elkay Water Solutions Corp, trading on the NYSE under the ticker ZWS, is a global provider of water delivery and plumbing products. The company was established in October 2022 through a spin-off from Rexnord Corp, creating a standalone business focused on designing, manufacturing and marketing water system components for residential, commercial and industrial customers.

Through its Zurn segment, the company offers solutions for water delivery, drainage and waste evacuation. Product lines include valves, hydrants, backflow prevention devices, piping systems, fittings and commercial waste stations.

Featured Articles Five stocks we like better than Zurn Elkay Water Solutions Cor VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over

Receive News & Ratings for Zurn Elkay Water Solutions Cor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zurn Elkay Water Solutions Cor and related companies with MarketBeat.com's FREE daily email newsletter.

 | Source: Comstock Inc.

VIRGINIA CITY, Nev., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”) today announced it has closed the previously announced transaction under which Mackay Precious Metals Inc. (“Mackay”), a wholly owned subsidiary of Mackay Gold & Silver Corp. (TSXV: MACK, OTCQB: MKGSF), acquired 100% of Comstock's mineral, mining, processing and mining-district-related real estate entities, with the aggregate transaction valued at more than $45 million. Comstock has now received $20 million in cash and 2 million common shares (TSX-V: MACK.V) of Mackay Gold & Silver Corp. currently valued at approximately $4.5 million and we expect to record a gain in a range of approximately $10 million to $12 million. The gain on the sale is not expected to result in any cash taxes.

The transaction included the sale of all four of the Company’s mining subsidiaries – Comstock Mining LLC, Comstock Processing LLC, Comstock Exploration and Development LLC, and Comstock Real Estate Inc. – including all mining claims (patented and unpatented), town lots, processing facilities, operating permits and water rights. Mackay also assumed all of the reclamation obligations and other liabilities associated with the sold entities, along with all associated reclamation and surety bond deposits and collateral.

“This transaction completes another critical objective in our transformation from a hard rock junior mining company into a growing, global, renewable metals and materials company. The transaction enhances balance sheet liquidity, reduces company-wide operating costs and realizes accretive value for our shareholders. This continues our strategy of allocating resources to fund our solar recycling production and growth in a manner that seeks to avoid shareholder dilution,” stated Corrado De Gasperis, Comstock’s CEO. “Closing this transaction simplifies our business, focuses our capacity, and reduces costs while retaining upside through both equity in Mackay Gold & Silver Corp. and future gold and silver NSR royalties.”

A secured, second-tranche payment of $7 million is due within 18 months.

Per the sales agreement, Comstock retains a 1.5% NSR royalty from sales of silver, gold, and all other valuable minerals and products extracted from the sold properties, subject to the terms of the Royalty Agreement which was executed at closing. Mackay has the option to buy out the royalty at any time for $3.5 million in cash. Comstock will further share in the success of Mackay’s exploration and development activities through a contingent payment of $10 million if, within seven years following closing, (i) Mackay makes a decision to proceed with the construction of a mine on any of the properties, or (ii) Mackay is sold, merged, or otherwise participates in a change-of-control transaction with aggregate consideration of at least $500 million. If the contingent payment does not occur, the value of the NSR buy out doubles to $7 million after seven years.

The divestiture will reduce ongoing payroll, permitting, environmental compliance, and related costs for maintaining these mining assets, resulting in an estimated $1.5 million in annual operational savings.

About Comstock Inc.

Comstock Inc. (NYSE: LODE) innovates and commercializes technologies, systems and supply chains that enable, support and sustain clean energy systems by efficiently, effectively, and expediently extracting and converting under-utilized natural resources into reusable metals, like silver, aluminum, gold, and other critical minerals, primarily from end-of-life photovoltaics and renewable fuels and other forms of energy.

To learn more, please visit www.comstock.inc.

Comstock Social Media Policy

Comstock Inc. has used, and intends to continue using, its investor relations link and main website at www.comstock.inc in addition to its X.com, LinkedIn and YouTube accounts, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts

For investor inquiries:
Judd B. Merrill, Chief Financial Officer
Tel (775) 413-6222
[email protected]

For media inquiries:
Zach Spencer, Director of External Relations
Tel (775) 847-7573
[email protected]

Forward-Looking Statements 

This press release and any related calls or discussions may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “forecast,” “seek,” “target,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: future market conditions; future financial, natural, and social gains; future prices and sales of, and demand for, our products and services; permits; production capacity and operations; operating and overhead costs; future capital expenditures and their impact on us; operational and management changes (including changes in the Board of Directors); changes in business strategies, planning and tactics; future employment and contributions of personnel, including consultants; future land and asset sales; investments, acquisitions, joint ventures, strategic alliances and business combinations; litigation, administrative or arbitration proceedings; environmental compliance and changes in the regulatory environment; offerings of equity or debt securities; and future working capital needs, revenues, variable costs, throughput rates, operating expenses, debt levels, cash flows, margins, taxes and earnings. These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties, many of which are unforeseeable and beyond our control and could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors set forth in our filings with the SEC. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows, or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Neither this press release nor any related calls or discussions constitutes an offer to sell, the solicitation of an offer to buy or a recommendation with respect to any securities of the Company or any other issuer.

 | Source: nVent

Leading manufacturer of engineered power distribution and infrastructure solutions for data centersBroadens nVent’s exposure to the high-growth infrastructure vertical, particularly in data centers, with a power distribution platform, complementing nVent’s data center offeringsExpands nVent’s offerings for new power architectures and system-level solutions and services for data centersExpect transaction to be accretive to adjusted EPS in the first year after completing the transaction LONDON, Aug. 24, 2026 (GLOBE NEWSWIRE) -- nVent Electric plc (NYSE: NVT) (“nVent”), a global leader in electrical connection and protection solutions, today announced that it has entered into a definitive agreement to acquire Maverick Power for a purchase price of $1.75 billion, subject to customary adjustments. The transaction also includes the potential additional consideration of up to $550 million in cash based on achieving certain performance metrics in 2027 and 2028. Maverick Power is a leading manufacturer of engineered power distribution and infrastructure solutions for data centers.

The acquisition of Maverick Power strengthens nVent’s position in the high-growth infrastructure vertical, particularly data centers. It will add a power distribution platform to nVent’s portfolio, complementing nVent’s data center offerings. Additionally, it will expand nVent’s offerings for new power architectures and system-level solutions and services for data centers.

“Maverick Power is a great fit for nVent and aligns with our strategy to focus on the high-growth infrastructure vertical,” said nVent Chair and CEO Beth Wozniak. “Maverick Power brings strong power distribution expertise and broadens our offerings to data center customers. We look forward to welcoming the Maverick Power team to nVent and together inventing the electrified future.”

Maverick Power President and CEO, Tom Currier added, “This is a significant milestone for our company, and we are thrilled to be joining nVent. nVent's strategy, culture, focus on people and customer-first approach are highly complementary to ours. Together, we will deliver a broader power and cooling portfolio for data center customers.”

Maverick Power is a leading North American provider of engineered power distribution and infrastructure solutions, including low-voltage switchgear and switchboards, medium-voltage switchgear, integrated modular solutions, and services.

Headquartered in McKinney, Texas, Maverick Power has approximately 900 employees in Texas and Arizona, with estimated 2026 revenues to be approximately $700 million. The business has a strong backlog and future demand visibility.

nVent expects the acquisition to be accretive to adjusted earnings per share in the first year following completion of the transaction.

The effective enterprise value multiple based on the $1.75 billion purchase price is approximately 11.5 times anticipated 2026 adjusted EBITDA. When adjusted for the present value of expected tax benefits the 2026 adjusted EBITDA multiple is approximately 10.5 times. nVent’s financial returns on the acquisition are expected to be significantly better if the potential additional considerations are paid.

The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions, including regulatory approval. nVent expects to fund the acquisition with a combination of available cash on hand and new debt.

Foley & Lardner LLP is providing legal counsel to nVent in connection with the transaction. Bank of America is providing nVent with committed bridge financing for the transaction.

ABOUT NVENT

nVent is a leading global provider of electrical connection and protection solutions. We believe our inventive electrical solutions enable safer systems and ensure a more secure world. We design, manufacture, market, install and service high-performance products and solutions that connect and protect some of the world's most sensitive equipment, buildings and critical processes. We offer a comprehensive range of systems protection and electrical connections solutions across industry-leading brands that are recognized globally for quality, reliability and innovation. Our principal office is in London and our management office in the United States is in Minneapolis. Our robust portfolio of leading electrical product brands dates back more than 100 years and includes nVent CADDY, ERICO, HOFFMAN, ILSCO, SCHROFF and TRACHTE. Learn more at www.nvent.com.

nVent, CADDY, ERICO, HOFFMAN, ILSCO, SCHROFF and TRACHTE are trademarks owned or licensed by nVent Services GmbH or its affiliates.
CAUTION CONCERNING FORWARD-LOOKING STATEMENTS

This press release contains statements that we believe to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are forward-looking statements. Without limitation, any statements preceded or followed by or that include the words “targets,” “plans,” “believes,” “expects,” “intends,” “will,” “likely,” “may,” “anticipates,” “estimates,” “projects,” “forecasts,” “should,” “would,” “could,” “positioned,” “strategy,” “future,” “are confident,” or words, phrases or terms of similar substance or the negative thereof, are forward-looking statements. All statements made about the anticipated acquisition, including the anticipated time for completing the acquisition, the expected financial results of the acquired business and the anticipated benefits of the acquisition, are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, assumptions and other factors, some of which are beyond our control, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Among these factors are our ability to close the acquisition on the expected terms and schedule; our ability to integrate the acquisition successfully; our ability to retain customers and employees of the acquired business; adverse effects on our business operations or financial results, including the overall global economic and business conditions impacting our business; the ability to achieve the benefits of our restructuring plans; the ability to successfully identify, finance, complete and integrate acquisitions; competition and pricing pressures in the markets we serve, including the impacts of tariffs; volatility in currency exchange rates, interest rates and commodity prices; inability to generate savings from excellence in operations initiatives consisting of lean enterprise, supply management and cash flow practices; inability to mitigate material and other cost inflation; risks related to the availability of, and cost inflation in, supply chain inputs, including labor, raw materials, commodities, packaging and transportation; increased risks associated with operating foreign businesses, including risks associated with military conflicts; the ability to deliver backlog and win future project work; failure of markets to accept new product introductions and enhancements; the impact of changes in laws and regulations, including those that limit U.S. tax benefits; the outcome of litigation and governmental proceedings; and the ability to achieve our long-term strategic operating goals. Additional information concerning these and other factors is contained in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. All forward-looking statements speak only as of the date of this press release. nVent assumes no obligation, and disclaims any obligation, to update the information contained in this press release.

Investor Contact
Tony Riter
Vice President, Investor Relations and Treasury
nVent
763.204.7750
[email protected]

Media Contact
Kevin King
Vice President, Global Communications
nVent
763.291.0526
[email protected]

Polymarket, the crypto-based prediction platform, puts the probability of no new Gemini Pro release before 30 September at 69%.

Every specific launch date on the market trades in low single digits, with 28 September the next most favoured outcome at 8%.

The bet centres on Gemini 3.5 Pro, the model Sundar Pichai promised developers would arrive within a month at Google's I/O conference on 19 May.

That deadline has come and gone three times over. The model missed targets in June, mid-July and early August, and as of late August still has no model identifier, no pricing and no launch date.

Google DeepMind's own models page continues to list it as coming soon. The hold-up is technical. Google has fallen months behind because it has been trying to improve the model's capabilities, particularly in coding.

The company reset and updated its training data in late June to fix the code-generation problems, only for internal results to disappoint again.

The delay carries a competitive cost. Google engineers and researchers are reported to be concerned that the company risks losing its edge as Anthropic and OpenAI ship models that outperform Gemini.

Rivals have not stood still. OpenAI launched its GPT-5.6 family in July, and Elon Musk's Grok 4.5 opened to the public in the same window.

Anthropic, meanwhile, has rolled out its Fable 5 model. Rather than rush the Pro release, Google has filled the gap with cheaper, faster models.

It has shipped a run of Flash models, with Gemini 3.7 Flash reaching general availability on 13 August.

The awkward result is that the strongest Gemini model users can currently call is not a Pro model at all.

Google has also confirmed it has begun pre-training an entirely new flagship, Gemini 4. That has fuelled speculation that the company may effectively skip ahead rather than salvage the delayed release.

Traders appear unconvinced a fix is imminent. A related Polymarket contract puts the chance of no Pro model by 1 November at roughly even.

Danica Pension Livsforsikringsaktieselskab decreased its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 23.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 148,161 shares of the company’s stock after selling 44,979 shares during the quarter. Danica Pension Livsforsikringsaktieselskab’s holdings in Procter & Gamble were worth $21,726,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of PG. Vanguard Group Inc. raised its position in Procter & Gamble by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company’s stock valued at $34,030,358,000 after purchasing an additional 2,829,151 shares during the last quarter. BlackRock Inc. bought a new stake in shares of Procter & Gamble in the 2nd quarter worth approximately $27,862,105,000. State Street Corp grew its position in shares of Procter & Gamble by 1.0% in the 4th quarter. State Street Corp now owns 101,618,926 shares of the company’s stock worth $14,563,008,000 after buying an additional 984,102 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Procter & Gamble by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 62,647,882 shares of the company’s stock valued at $8,962,689,000 after buying an additional 1,974,556 shares during the period. Finally, Norges Bank purchased a new position in shares of Procter & Gamble during the fourth quarter valued at approximately $4,664,783,000. 65.77% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In PG has been the subject of a number of research analyst reports. Citigroup dropped their price target on Procter & Gamble from $181.00 to $170.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. Argus downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Friday, August 7th. BMO Capital Markets upped their price objective on shares of Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a report on Monday, June 29th. Jefferies Financial Group raised their target price on shares of Procter & Gamble from $177.00 to $179.00 and gave the stock a “buy” rating in a research report on Friday, June 26th. Finally, TD Cowen lifted their target price on shares of Procter & Gamble from $142.00 to $150.00 and gave the company a “hold” rating in a research note on Monday, April 27th. Thirteen equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus price target of $161.52.

Get Our Latest Stock Report on PG Shares of NYSE:PG opened at $144.77 on Monday. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $167.25. The firm has a market capitalization of $336.51 billion, a P/E ratio of 21.87, a P/E/G ratio of 4.46 and a beta of 0.39. The stock has a 50 day moving average price of $147.73 and a 200-day moving average price of $148.66. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68.

Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. The company had revenue of $21.20 billion during the quarter, compared to analysts’ expectations of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.The firm’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, equities research analysts anticipate that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Monday, August 17th. Shareholders of record on Friday, July 24th were given a dividend of $1.0885 per share. The ex-dividend date of this dividend was Friday, July 24th. This represents a $4.35 annualized dividend and a yield of 3.0%. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.71%.

About Procter & Gamble (Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

See Also Five stocks we like better than Procter & Gamble VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.

In rural west Texas where oil rigs and pump jacks dot the sparse flat ​landscape, an ExxonMobil (XOM.N) contractor sits in a small office on a drilling rig, using controls on a screen to operate robotic ‌machinery and move tall steel pipes weighing roughly 2,000 pounds.

This work would usually require human overseers standing on the rig floor, the most common location for accidents on a rig.

Exxon, the largest oil producer by volume in the U.S., operates more than 30 drilling rigs in the Permian Basin, two of which are automated rigs with robotic equipment. By 2028, the company ​aims to transition half of its fleet to automated rigs to reduce the need for workers to perform potentially dangerous work and increase ​efficiency to drill wells faster, an executive told Reuters.

The Permian Basin in Texas and New Mexico, the biggest U.S. ⁠oilfield, revolutionized energy markets two decades ago when development of the shale basin turned the U.S. into one of the leading oil-producing countries. But the relatively ​quick decline rate of shale wells has prompted drillers to develop more technologies to extract the oil. Some in the industry are also concerned about when the ​Permian's production could begin to decline.

Exxon plans to grow its Permian production by almost 40% to 2.5 million barrels of oil equivalent per day by 2030. By contrast, rival oil major Chevron plans to hold production steady at about 1 million boepd, focusing instead on free cash flow.

The automated drilling rigs are part of a combination of technologies and strategies Exxon ​is using to boost production, said Bart Cahir, Exxon's senior vice president of unconventionals, in an interview on the rig.

"When we take people off the ​rig floor, those same individuals are now able to think ahead and plan for the next operation and that combination gives us efficiency," he said. "This is the productivity play."

The ‌company installed ⁠its first automated rig, supplied by drilling contractor Helmerich & Payne (HP.N), last year. It drilled two miles horizontally underground in a little over six days, the third fastest time in Exxon's history.

Exxon's use of automated rigs in the Permian and its goal of expanding the fleet has not been previously reported.

REDUCING RISK AND DRILLING MORE
On one of Exxon's automated rigs in Midland, a gate surrounds the drilling floor with a sign reading "Red Zone: Restricted Area." A drawing of the Grim Reaper illustrates the ​risk that workers face around heavy ​equipment and pressurized systems.

Where workers would ⁠usually help move columns of drill pipe over two stories tall, robotic arms now position the pipes and connect them to a drill string. This allows drilling to continue deeper into the wellbore.

Employees on the rig communicate with Exxon's ​central operations team in Houston to determine the precise movements the robotic system should make.

Removing workers from the so-called ​Red Zones allows ⁠them to focus on other operations on the rig and reduces variability in the work, meaning more feet per day can be drilled, Cahir said.

"In the history of well drilling activity, about a third of significant injuries that occur happen on the rig floor," he said. "By getting people out of that higher risk area, we're essentially ⁠eliminating that risk."

Exxon ​plans to expand automated rigs to a quarter of the fleet next year and then ​half of the fleet by 2028, Cahir said.

Exxon is also developing a suite of more than 40 technologies to double its oil recovery from the Permian by the early 2030s. The shale ​industry typically extracts just 10% of the oil in the ground due to the tight, compacted rock.

Danica Pension Livsforsikringsaktieselskab purchased a new position in Starbucks Corporation (NASDAQ:SBUX – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 132,632 shares of the coffee company’s stock, valued at approximately $13,554,000.

Other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. bought a new position in shares of Starbucks in the 2nd quarter valued at $8,504,509,000. Norges Bank acquired a new position in shares of Starbucks in the fourth quarter valued at approximately $1,232,650,000. T. Rowe Price Investment Management Inc. increased its position in Starbucks by 65.9% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 19,447,854 shares of the coffee company’s stock valued at $1,637,704,000 after acquiring an additional 7,725,547 shares during the period. Bank of New York Mellon Corp acquired a new stake in Starbucks in the second quarter valued at $779,790,000. Finally, Capital World Investors increased its stake in shares of Starbucks by 9.0% in the fourth quarter. Capital World Investors now owns 84,727,405 shares of the coffee company’s stock valued at $7,135,228,000 after buying an additional 7,007,268 shares during the period. 72.29% of the stock is owned by institutional investors.

Starbucks Price Performance NASDAQ SBUX opened at $107.08 on Monday. The firm’s 50-day simple moving average is $104.45 and its two-hundred day simple moving average is $100.43. The company has a market cap of $122.07 billion, a PE ratio of 61.54, a price-to-earnings-growth ratio of 1.85 and a beta of 0.97. Starbucks Corporation has a 52 week low of $77.99 and a 52 week high of $110.51.

Starbucks (NASDAQ:SBUX – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The coffee company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.66 by $0.19. The business had revenue of $9.32 billion during the quarter, compared to analyst estimates of $9.17 billion. Starbucks had a net margin of 5.17% and a negative return on equity of 34.10%. Starbucks’s revenue was down 1.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.50 EPS. Starbucks has set its FY 2026 guidance at 2.550-2.650 EPS. As a group, equities research analysts anticipate that Starbucks Corporation will post 2.64 EPS for the current year. Starbucks Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Friday, August 14th will be issued a dividend of $0.62 per share. This represents a $2.48 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Friday, August 14th. Starbucks’s dividend payout ratio is 142.53%.

Wall Street Analysts Forecast Growth A number of equities analysts recently weighed in on the stock. BNP Paribas Exane lifted their target price on shares of Starbucks from $87.00 to $92.00 and gave the stock an “underperform” rating in a research note on Thursday, July 30th. Raymond James Financial lowered Starbucks to an “outperform” rating in a research report on Monday, August 3rd. Scotiabank lowered shares of Starbucks from a “market perform” rating to an “underperform” rating in a report on Thursday, May 14th. TD Cowen reaffirmed a “buy” rating on shares of Starbucks in a report on Tuesday, August 18th. Finally, Robert W. Baird set a $124.00 target price on shares of Starbucks in a research report on Thursday, July 30th. Nineteen equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $110.30.

View Our Latest Stock Report on Starbucks

More Starbucks News Here are the key news stories impacting Starbucks this week:

Positive Sentiment: Starbucks is eliminating more than 200 corporate positions as part of a broader restructuring and approximately $2 billion cost-reduction effort. Lower overhead could support profitability if the company maintains service levels and directs more resources toward its stores. The reductions do not involve cafe closures. Starbucks trims corporate ranks as coffeehouse investments deliver Positive Sentiment: Recent market commentary highlights Starbucks’ roughly 25% 2026 gain and suggests investors are rewarding its operational reset and investments in the cafe experience. The rally follows the company’s latest quarterly earnings beat, with adjusted EPS of $0.85 versus a $0.66 consensus estimate and revenue above expectations. Neutral Sentiment: The restructuring is relocating some corporate operations to a new, approximately $100 million Nashville office. Around 120 Seattle employees reportedly declined the move, while another 104 roles in store design and construction are being eliminated. Management characterizes the actions as part of the restructuring winding down, but the savings and impact on execution remain to be demonstrated. Starbucks cuts another 224 Seattle jobs Negative Sentiment: Starbucks continues to face challenges in China, where domestic competitors, shifting consumer preferences and geopolitical tensions are eroding the position of major U.S. brands. China weakness could limit international growth and pressure comparable sales. Why some of America’s biggest brands are losing ground in China Negative Sentiment: The stock’s strong performance has also produced a demanding valuation, with the supplied data showing a P/E ratio above 60. Investors may require sustained earnings growth from the turnaround to justify the premium, leaving SBUX vulnerable to disappointment. Insiders Place Their Bets In other news, CEO Brady Brewer sold 2,229 shares of Starbucks stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $105.99, for a total transaction of $236,251.71. Following the completion of the sale, the chief executive officer owned 75,135 shares in the company, valued at approximately $7,963,558.65. This trade represents a 2.88% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 6,687 shares of company stock valued at $681,663. 0.03% of the stock is owned by corporate insiders.

Starbucks Company Profile (Free Report)

Starbucks Corporation is a global coffeehouse chain and roaster that operates, licenses and franchises coffee shops and related retail businesses. Founded in Seattle, Washington in 1971 by Jerry Baldwin, Zev Siegl and Gordon Bowker, the company grew from a single store focused on whole-bean coffee and equipment into a broad consumer-facing brand. Howard Schultz, who joined the company later and served in senior leadership roles, is widely credited with transforming Starbucks into a mass-market specialty coffee retailer and expanding its footprint internationally.

Starbucks’ core activities center on the retail sale of hot and cold specialty beverages, whole-bean and packaged coffees, teas and ready-to-drink products, along with complementary food items and merchandise such as mugs and brewing equipment.

See Also Five stocks we like better than Starbucks VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over

Receive News & Ratings for Starbucks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starbucks and related companies with MarketBeat.com's FREE daily email newsletter.

Compass Wealth Management LLC acquired a new position in Starbucks Corporation (NASDAQ:SBUX – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 86,114 shares of the coffee company’s stock, valued at approximately $8,800,000. Starbucks accounts for about 1.7% of Compass Wealth Management LLC’s portfolio, making the stock its 13th biggest holding.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Rachor Investment Advisory Services LLC purchased a new position in Starbucks during the 4th quarter valued at about $25,000. Cornerstone Financial Management LLC purchased a new stake in shares of Starbucks in the 4th quarter worth approximately $25,000. Phillip James Consulting Co. purchased a new stake in shares of Starbucks in the 4th quarter worth approximately $25,000. Meeder Asset Management Inc. bought a new position in shares of Starbucks during the second quarter valued at approximately $25,000. Finally, Entrust Financial LLC bought a new position in shares of Starbucks during the fourth quarter valued at approximately $26,000. 72.29% of the stock is currently owned by institutional investors.

Insiders Place Their Bets In related news, CEO Brady Brewer sold 2,229 shares of the company’s stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $105.99, for a total transaction of $236,251.71. Following the transaction, the chief executive officer directly owned 75,135 shares of the company’s stock, valued at $7,963,558.65. This represents a 2.88% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 6,687 shares of company stock worth $681,663. 0.03% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth A number of equities analysts recently commented on the stock. Evercore reissued an “outperform” rating on shares of Starbucks in a research note on Thursday, July 30th. Robert W. Baird set a $124.00 target price on Starbucks in a report on Thursday, July 30th. Jefferies Financial Group assumed coverage on Starbucks in a research report on Thursday, May 14th. They set a “buy” rating on the stock. BTIG Research reiterated a “buy” rating and issued a $115.00 price target on shares of Starbucks in a report on Friday, July 31st. Finally, Melius Research set a $110.00 price target on Starbucks in a research report on Monday, August 3rd. Nineteen equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $110.30. View Our Latest Research Report on Starbucks

Starbucks Price Performance NASDAQ:SBUX opened at $107.08 on Monday. The stock has a market capitalization of $122.07 billion, a price-to-earnings ratio of 61.54, a PEG ratio of 1.85 and a beta of 0.97. Starbucks Corporation has a 52 week low of $77.99 and a 52 week high of $110.51. The firm has a 50 day moving average of $104.45 and a 200 day moving average of $100.43.

Starbucks (NASDAQ:SBUX – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The coffee company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.19. The business had revenue of $9.32 billion for the quarter, compared to analyst estimates of $9.17 billion. Starbucks had a net margin of 5.17% and a negative return on equity of 34.10%. The business’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.50 earnings per share. Starbucks has set its FY 2026 guidance at 2.550-2.650 EPS. As a group, analysts expect that Starbucks Corporation will post 2.64 EPS for the current year.

Starbucks Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Friday, August 14th will be paid a dividend of $0.62 per share. This represents a $2.48 annualized dividend and a yield of 2.3%. The ex-dividend date is Friday, August 14th. Starbucks’s payout ratio is 142.53%.

Starbucks News Summary Here are the key news stories impacting Starbucks this week:

Positive Sentiment: Starbucks is eliminating more than 200 corporate positions as part of a broader restructuring and approximately $2 billion cost-reduction effort. Lower overhead could support profitability if the company maintains service levels and directs more resources toward its stores. The reductions do not involve cafe closures. Starbucks trims corporate ranks as coffeehouse investments deliver Positive Sentiment: Recent market commentary highlights Starbucks’ roughly 25% 2026 gain and suggests investors are rewarding its operational reset and investments in the cafe experience. The rally follows the company’s latest quarterly earnings beat, with adjusted EPS of $0.85 versus a $0.66 consensus estimate and revenue above expectations. Neutral Sentiment: The restructuring is relocating some corporate operations to a new, approximately $100 million Nashville office. Around 120 Seattle employees reportedly declined the move, while another 104 roles in store design and construction are being eliminated. Management characterizes the actions as part of the restructuring winding down, but the savings and impact on execution remain to be demonstrated. Starbucks cuts another 224 Seattle jobs Negative Sentiment: Starbucks continues to face challenges in China, where domestic competitors, shifting consumer preferences and geopolitical tensions are eroding the position of major U.S. brands. China weakness could limit international growth and pressure comparable sales. Why some of America’s biggest brands are losing ground in China Negative Sentiment: The stock’s strong performance has also produced a demanding valuation, with the supplied data showing a P/E ratio above 60. Investors may require sustained earnings growth from the turnaround to justify the premium, leaving SBUX vulnerable to disappointment. About Starbucks (Free Report)

Starbucks Corporation is a global coffeehouse chain and roaster that operates, licenses and franchises coffee shops and related retail businesses. Founded in Seattle, Washington in 1971 by Jerry Baldwin, Zev Siegl and Gordon Bowker, the company grew from a single store focused on whole-bean coffee and equipment into a broad consumer-facing brand. Howard Schultz, who joined the company later and served in senior leadership roles, is widely credited with transforming Starbucks into a mass-market specialty coffee retailer and expanding its footprint internationally.

Starbucks’ core activities center on the retail sale of hot and cold specialty beverages, whole-bean and packaged coffees, teas and ready-to-drink products, along with complementary food items and merchandise such as mugs and brewing equipment.

See Also Five stocks we like better than Starbucks VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over

Receive News & Ratings for Starbucks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starbucks and related companies with MarketBeat.com's FREE daily email newsletter.

Biondo Investment Advisors LLC acquired a new stake in shares of Chevron Corporation (NYSE:CVX – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 73,440 shares of the oil and gas company’s stock, valued at approximately $12,173,000. Chevron accounts for about 1.5% of Biondo Investment Advisors LLC’s investment portfolio, making the stock its 23rd biggest holding.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CVX. Blue Capital Inc. bought a new position in Chevron during the second quarter valued at about $786,000. OneAscent Wealth Management LLC bought a new stake in shares of Chevron during the 2nd quarter worth about $973,000. Global Retirement Partners LLC acquired a new position in shares of Chevron during the 2nd quarter valued at about $14,276,000. Indivisible Partners acquired a new position in shares of Chevron during the 4th quarter valued at about $1,923,000. Finally, Janney Montgomery Scott LLC raised its stake in shares of Chevron by 6.8% in the 1st quarter. Janney Montgomery Scott LLC now owns 1,251,102 shares of the oil and gas company’s stock valued at $258,853,000 after acquiring an additional 79,439 shares in the last quarter. Institutional investors and hedge funds own 72.42% of the company’s stock.

Analysts Set New Price Targets Several equities research analysts recently weighed in on CVX shares. Dbs Bank upgraded Chevron to a “moderate buy” rating in a report on Thursday, August 6th. Sanford C. Bernstein lifted their price target on shares of Chevron from $204.00 to $209.00 and gave the company a “market perform” rating in a research report on Monday, August 3rd. Zacks Research cut shares of Chevron from a “strong-buy” rating to a “hold” rating in a research note on Monday, June 8th. Piper Sandler initiated coverage on shares of Chevron in a research note on Thursday, July 23rd. They issued an “overweight” rating and a $207.00 target price on the stock. Finally, Morgan Stanley lifted their target price on shares of Chevron from $210.00 to $218.00 and gave the stock an “overweight” rating in a report on Wednesday. Twenty equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Chevron presently has an average rating of “Moderate Buy” and a consensus target price of $207.48.

View Our Latest Stock Report on Chevron Insider Transactions at Chevron In related news, Director John B. Hess sold 710,665 shares of the firm’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $194.10, for a total value of $137,940,076.50. Following the completion of the transaction, the director directly owned 363,711 shares of the company’s stock, valued at $70,596,305.10. This trade represents a 66.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Andrew Benjamin Walz sold 16,800 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $201.06, for a total transaction of $3,377,808.00. Following the completion of the sale, the insider directly owned 14 shares in the company, valued at $2,814.84. This trade represents a 99.92% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 1,152,582 shares of company stock valued at $225,853,661 in the last ninety days. 0.56% of the stock is owned by company insiders.

Chevron Stock Down 0.0% CVX stock opened at $205.25 on Monday. Chevron Corporation has a twelve month low of $146.49 and a twelve month high of $214.71. The company has a market cap of $405.53 billion, a PE ratio of 19.68, a price-to-earnings-growth ratio of 0.61 and a beta of 0.49. The business’s 50-day simple moving average is $185.03 and its 200 day simple moving average is $188.17. The company has a quick ratio of 0.98, a current ratio of 1.25 and a debt-to-equity ratio of 0.19.

Chevron (NYSE:CVX – Get Free Report) last posted its quarterly earnings results on Friday, July 31st. The oil and gas company reported $6.06 EPS for the quarter, beating the consensus estimate of $5.55 by $0.51. Chevron had a return on equity of 11.09% and a net margin of 9.57%.The firm had revenue of $67.20 billion during the quarter, compared to analysts’ expectations of $62.72 billion. During the same quarter in the prior year, the firm posted $1.77 EPS. The company’s revenue for the quarter was up 57.4% on a year-over-year basis. On average, research analysts anticipate that Chevron Corporation will post 16.17 earnings per share for the current year.

Chevron Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Thursday, September 10th. Investors of record on Wednesday, August 19th will be paid a $1.78 dividend. This represents a $7.12 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date is Wednesday, August 19th. Chevron’s dividend payout ratio is presently 68.26%.

Key Stories Impacting Chevron Here are the key news stories impacting Chevron this week:

Positive Sentiment: Brent crude recently approached $94–$95 per barrel amid renewed Middle East tensions and concerns about Strait of Hormuz disruptions. Sustained higher oil prices typically benefit Chevron’s upstream revenue, margins and cash flow. Chevron jumps as Brent crude approaches $94 Positive Sentiment: Chevron confirmed an oil and gas condensate discovery at the 105-4X well in offshore Angola. Its proximity to existing facilities could allow a lower-cost tie-back, creating a potential source of future production. Chevron Angola discovery analysis Positive Sentiment: Chevron’s $1.78 quarterly dividend, equal to $7.12 annually and an approximately 3.5% yield, reinforces its appeal to income investors. The company also recently exceeded quarterly earnings and revenue expectations. Chevron raises dividend Neutral Sentiment: Analysis comparing Chevron with Exxon Mobil highlights differing long-term strategies, including Chevron’s continued emphasis on oil and gas. The approach could benefit from strong commodity prices but leaves CVX more exposed to future oil-demand and price cycles. Chevron versus Exxon Mobil analysis Negative Sentiment: Iraq plans to more than double its oil output over the next six years. If achieved, the added supply could pressure global crude prices and reduce the earnings benefit Chevron receives from today’s elevated prices. Iraq oil output and Chevron Negative Sentiment: Two Chevron insiders sold shares recently: Andrew Benjamin Walz sold 16,800 shares, while R. Hewitt Pate sold 2,470 shares. Although such transactions may reflect personal financial planning, they can create a modest sentiment overhang. Chevron insider sale report Negative Sentiment: A separate analysis says concerns remain centered on Chevron, including issues surrounding its Hess Midstream exposure and broader execution risks. The report may temper enthusiasm after CVX’s recent advance. Hess Midstream: The Issue Remains With Chevron About Chevron (Free Report)

Chevron Corporation (NYSE: CVX) is an American multinational energy company engaged in virtually all aspects of the oil and gas industry. As an integrated energy firm, Chevron’s core activities include upstream oil and natural gas exploration and production, midstream transportation and storage, downstream refining and marketing of fuels and lubricants, and petrochemical manufacturing through joint ventures and subsidiaries. The company markets fuels under brands such as Chevron, Texaco and Caltex and supplies a range of products and services to retail customers, industrial users and commercial fleets worldwide.

Chevron traces its corporate lineage to the early petroleum companies that eventually became Standard Oil of California and has evolved through significant mergers and restructurings, including the acquisitions of Gulf Oil and Texaco.

Featured Stories Five stocks we like better than Chevron VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over

Receive News & Ratings for Chevron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chevron and related companies with MarketBeat.com's FREE daily email newsletter.

Bank of Nova Scotia purchased a new position in shares of T-Mobile US, Inc. (NASDAQ:TMUS – Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 296,063 shares of the Wireless communications provider’s stock, valued at approximately $49,659,000.

Other large investors also recently bought and sold shares of the company. Main Street Group LTD purchased a new stake in shares of T-Mobile US in the first quarter valued at approximately $25,000. JDM Financial Group LLC boosted its stake in T-Mobile US by 114.0% during the fourth quarter. JDM Financial Group LLC now owns 122 shares of the Wireless communications provider’s stock worth $25,000 after buying an additional 65 shares during the last quarter. Swiss RE Ltd. acquired a new position in T-Mobile US during the fourth quarter worth $29,000. Paladin Partners LLC purchased a new stake in T-Mobile US in the 2nd quarter valued at $25,000. Finally, Turning Point Benefit Group Inc. grew its holdings in T-Mobile US by 3,825.0% in the 4th quarter. Turning Point Benefit Group Inc. now owns 157 shares of the Wireless communications provider’s stock valued at $32,000 after buying an additional 153 shares in the last quarter. Hedge funds and other institutional investors own 42.49% of the company’s stock.

T-Mobile US Stock Performance Shares of TMUS stock opened at $183.04 on Monday. T-Mobile US, Inc. has a 1-year low of $165.66 and a 1-year high of $261.25. The firm has a market cap of $196.34 billion, a PE ratio of 19.17, a price-to-earnings-growth ratio of 1.03 and a beta of 0.33. The company has a 50-day moving average of $181.42 and a two-hundred day moving average of $193.97. The company has a debt-to-equity ratio of 1.48, a current ratio of 0.92 and a quick ratio of 0.83.

T-Mobile US (NASDAQ:TMUS – Get Free Report) last posted its earnings results on Thursday, July 23rd. The Wireless communications provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.59 by $0.40. T-Mobile US had a net margin of 11.45% and a return on equity of 20.16%. The firm had revenue of $22.79 billion during the quarter, compared to the consensus estimate of $22.95 billion. During the same quarter last year, the firm earned $2.84 EPS. The firm’s revenue for the quarter was up 7.9% on a year-over-year basis. On average, analysts predict that T-Mobile US, Inc. will post 10.73 EPS for the current year. T-Mobile US Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Thursday, September 10th. Investors of record on Friday, August 28th will be paid a dividend of $1.02 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $4.08 annualized dividend and a yield of 2.2%. T-Mobile US’s dividend payout ratio is presently 42.72%.

Analyst Upgrades and Downgrades Several research analysts have recently commented on TMUS shares. Wall Street Zen upgraded T-Mobile US from a “sell” rating to a “hold” rating in a report on Saturday, May 2nd. Scotiabank dropped their price objective on shares of T-Mobile US from $263.00 to $243.00 and set a “sector outperform” rating for the company in a report on Wednesday, July 15th. Bank of America upgraded shares of T-Mobile US from a “neutral” rating to a “buy” rating and set a $220.00 price objective for the company in a research report on Monday, July 6th. Morgan Stanley decreased their target price on shares of T-Mobile US from $260.00 to $230.00 and set an “overweight” rating on the stock in a report on Tuesday, July 7th. Finally, KeyCorp dropped their price target on shares of T-Mobile US from $260.00 to $250.00 and set an “overweight” rating for the company in a research note on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $252.08.

Get Our Latest Stock Analysis on T-Mobile US

About T-Mobile US (Free Report)

T-Mobile US is a national wireless carrier that provides mobile voice, messaging and data services to consumers, businesses and wholesale customers across the United States, Puerto Rico and the U.S. Virgin Islands. The company operates a nationwide mobile network and offers device sales, equipment financing and support services through retail stores, online channels and distribution partners. T-Mobile positions its products around bundled service plans, device offerings and value-added features for both individual and enterprise customers.

Product offerings include postpaid and prepaid wireless plans under the T-Mobile and Metro by T-Mobile brands, as well as connectivity solutions for small and large businesses.

See Also Five stocks we like better than T-Mobile US VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over Want to see what other hedge funds are holding TMUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for T-Mobile US, Inc. (NASDAQ:TMUS – Free Report).

Receive News & Ratings for T-Mobile US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T-Mobile US and related companies with MarketBeat.com's FREE daily email newsletter.

Barbara Oil Co. bought a new stake in Bristol Myers Squibb Company (NYSE:BMY – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 42,000 shares of the biopharmaceutical company’s stock, valued at approximately $2,420,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Davis Asset Management L.P. acquired a new position in shares of Bristol Myers Squibb in the 2nd quarter valued at about $27,000. Swiss RE Ltd. acquired a new stake in Bristol Myers Squibb during the 4th quarter worth approximately $25,000. Physician Wealth Advisors Inc. raised its holdings in Bristol Myers Squibb by 73.5% in the fourth quarter. Physician Wealth Advisors Inc. now owns 477 shares of the biopharmaceutical company’s stock valued at $26,000 after buying an additional 202 shares during the period. Darwin Wealth Management LLC purchased a new position in Bristol Myers Squibb in the second quarter valued at approximately $25,000. Finally, Addison Advisors LLC acquired a new position in Bristol Myers Squibb during the second quarter valued at approximately $32,000. Institutional investors and hedge funds own 76.41% of the company’s stock.

Bristol Myers Squibb Stock Up 0.1% Shares of NYSE BMY opened at $67.06 on Monday. Bristol Myers Squibb Company has a 1 year low of $42.52 and a 1 year high of $68.64. The firm has a market cap of $136.98 billion, a price-to-earnings ratio of 14.77, a PEG ratio of 0.17 and a beta of 0.22. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.38 and a current ratio of 1.53. The stock’s 50-day simple moving average is $60.55 and its 200-day simple moving average is $59.39.

Bristol Myers Squibb (NYSE:BMY – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The biopharmaceutical company reported $2.04 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.44. Bristol Myers Squibb had a return on equity of 66.90% and a net margin of 18.87%.The firm had revenue of $12.97 billion during the quarter, compared to the consensus estimate of $11.74 billion. During the same quarter in the prior year, the business posted $1.46 earnings per share. Bristol Myers Squibb’s revenue for the quarter was up 5.7% on a year-over-year basis. Bristol Myers Squibb has set its FY 2026 guidance at 6.750-7.000 EPS. As a group, equities analysts anticipate that Bristol Myers Squibb Company will post 6.95 earnings per share for the current fiscal year. Bristol Myers Squibb Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 2nd were paid a dividend of $0.63 per share. The ex-dividend date was Thursday, July 2nd. This represents a $2.52 annualized dividend and a yield of 3.8%. Bristol Myers Squibb’s dividend payout ratio is presently 55.51%.

Wall Street Analysts Forecast Growth Several equities research analysts have recently issued reports on the stock. Truist Financial reissued a “buy” rating and issued a $70.00 price objective (up from $65.00) on shares of Bristol Myers Squibb in a research report on Friday, July 31st. Guggenheim reaffirmed a “buy” rating and set a $75.00 price target (up from $72.00) on shares of Bristol Myers Squibb in a research report on Friday, July 31st. UBS Group downgraded Bristol Myers Squibb from a “buy” rating to a “neutral” rating in a report on Wednesday, August 5th. BMO Capital Markets reissued a “market perform” rating on shares of Bristol Myers Squibb in a research report on Monday, July 27th. Finally, Raymond James Financial initiated coverage on Bristol Myers Squibb in a research note on Wednesday, August 5th. They set a “strong-buy” rating on the stock. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Bristol Myers Squibb has an average rating of “Moderate Buy” and an average target price of $66.06.

Read Our Latest Research Report on BMY

Key Stories Impacting Bristol Myers Squibb Here are the key news stories impacting Bristol Myers Squibb this week:

Positive Sentiment: Bristol Myers Squibb plans to invest approximately $2.3 billion in a new Houston manufacturing facility, part of a broader $40 billion U.S. investment commitment. The project reinforces BMY’s confidence in domestic production capacity and could support long-term operational growth. Bristol-Myers Squibb Bets $2.3 Billion on Texas Positive Sentiment: BMY is collaborating with Chai Discovery on artificial-intelligence-driven antibody discovery. The partnership could help identify novel therapeutic candidates more efficiently and strengthens the company’s efforts to modernize its drug-development platform. Chai Discovery Collaboration Positive Sentiment: The company is launching a Phase 1 study of an early Alzheimer’s disease antibody. Although the program remains highly experimental, it adds another potential long-term growth opportunity to BMY’s pipeline. Early Alzheimer’s Antibody Study Positive Sentiment: Strong Eliquis performance is helping offset declines in BMY’s older products facing generic pressure, supporting a more favorable 2026 revenue outlook. Elevated call-option activity also signals increased bullish interest, though it is not a fundamental guarantee. Eliquis and Legacy Portfolio Analysis Neutral Sentiment: Early clinical work on navlimetostat shows continued pipeline activity, but the Phase 1-stage program has not yet produced efficacy data that would materially change near-term earnings expectations. Navlimetostat Study Update Negative Sentiment: Generic competition remains a key risk for BMY’s legacy portfolio. Investors must determine whether Eliquis growth and newer pipeline assets can replace revenue lost as established medicines face erosion. Legacy Portfolio Erosion Analysis Bristol Myers Squibb Profile (Free Report)

Bristol Myers Squibb is a global biopharmaceutical company headquartered in Princeton, New Jersey, focused on discovering, developing and delivering medicines for serious diseases. The company’s core activities include research and development, clinical development, manufacturing and commercialization of prescription pharmaceuticals across multiple therapeutic areas. BMS concentrates on advancing therapies in oncology, hematology, immunology, cardiovascular disease and specialty areas through both small molecules and biologics.

BMS’s marketed portfolio and late‑stage pipeline reflect a strong emphasis on cancer and immune‑mediated conditions.

Further Reading Five stocks we like better than Bristol Myers Squibb VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over

Receive News & Ratings for Bristol Myers Squibb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bristol Myers Squibb and related companies with MarketBeat.com's FREE daily email newsletter.

PDD Holdings heads into second-quarter earnings on Monday with Wall Street cautious about how quickly revenue growth can translate into stronger profits.

Analysts expect roughly $17.1 billion in revenue and adjusted earnings of about $2.75 per ADS. PDD shares closed Friday at $88.38, down 1.3%, after post-Q1 price-target cuts.

The shift is not outright bearishness. Temu is expanding internationally and PDD remains one of China’s largest e-commerce platforms.

The concern is that heavy investment and weak Chinese consumption have made near-term earnings difficult to forecast.

First-quarter revenue rose 11% year over year to 106.2 billion yuan, but adjusted net income fell 17% to 14.1 billion yuan.

Sales and marketing expenses reached 33.8 billion yuan, roughly 32% of revenue, as PDD continued investing across domestic and overseas markets.

That disconnect is now central to Monday’s report.

Macquarie analyst Ellie Jiang downgraded PDD to Neutral after the quarter and cut her target to $87 from $151.

According to StreetInsider, Jiang said the firm “struggle[s] to find tangible evidence to support a sustainable near-term earnings recovery.”

Macquarie cited lacklustre consumption, aggressive e-commerce competition and continued spending on supply chains and international expansion. It noted that sales and marketing costs had risen to 32% of revenue from 29% in 2025.

The issue is not whether PDD looks cheap. Investors are struggling to determine what level of sustainable earnings should underpin that valuation.

PDD also enters earnings with its home market under pressure.

Daiwa downgraded the stock to Hold in June and cut its target to $80 from $145 after China’s 6.18 shopping festival “delivered a negative surprise.”

Overall festival gross merchandise value rose just 0.9% year over year, compared with 15% growth in 2025. Daiwa described Chinese e-commerce consumption as “weak” and the macro backdrop as “tough.”

That makes Temu’s international expansion important.

Temu can offset slower domestic growth, but building overseas scale requires spending on customer acquisition, logistics, merchant incentives and localisation.

The question is whether the economics of that growth are improving quickly enough to stop international expansion from consuming an outsized share of group profits.

Not every analyst sees PDD’s higher investment as structural deterioration.

Citi analyst Alicia Yap retained a Buy rating after the first quarter, although she cut her target to $123 from $142.

According to TipRanks, Citi attributed the revenue disappointment partly to merchant subsidies and stepped-up investment in supply chains and first-party brands.

The bank supports that strategy, arguing successful execution could improve product quality for Chinese shoppers and Temu customers overseas.

That captures the debate heading into earnings.

PDD must show how much it is spending to generate growth and when that spending can begin producing a stronger earnings payoff.

Barbara Oil Co. acquired a new stake in shares of Union Pacific Corporation (NYSE:UNP – Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 15,000 shares of the railroad operator’s stock, valued at approximately $4,080,000. Union Pacific accounts for 1.4% of Barbara Oil Co.’s portfolio, making the stock its 21st biggest holding.

Other hedge funds also recently bought and sold shares of the company. Tiemann Investment Advisors LLC increased its stake in Union Pacific by 1.7% in the 2nd quarter. Tiemann Investment Advisors LLC now owns 2,117 shares of the railroad operator’s stock worth $576,000 after buying an additional 35 shares during the period. TFR Capital LLC. boosted its position in Union Pacific by 3.8% in the 2nd quarter. TFR Capital LLC. now owns 979 shares of the railroad operator’s stock valued at $266,000 after buying an additional 36 shares during the period. Key Financial Inc grew its stake in Union Pacific by 2.1% in the 1st quarter. Key Financial Inc now owns 1,821 shares of the railroad operator’s stock worth $442,000 after acquiring an additional 38 shares in the last quarter. Members Trust Co grew its stake in Union Pacific by 2.5% in the 1st quarter. Members Trust Co now owns 1,573 shares of the railroad operator’s stock worth $382,000 after acquiring an additional 38 shares in the last quarter. Finally, EJMK Ventures LLC grew its stake in Union Pacific by 4.0% in the 1st quarter. EJMK Ventures LLC now owns 1,016 shares of the railroad operator’s stock worth $247,000 after acquiring an additional 39 shares in the last quarter. Institutional investors own 80.38% of the company’s stock.

Union Pacific Stock Performance Shares of UNP stock opened at $307.97 on Monday. The firm has a market cap of $182.96 billion, a price-to-earnings ratio of 24.94, a PEG ratio of 3.14 and a beta of 0.96. The company’s 50 day moving average is $286.30 and its 200 day moving average is $267.83. The company has a quick ratio of 0.82, a current ratio of 0.99 and a debt-to-equity ratio of 1.40. Union Pacific Corporation has a 52-week low of $210.84 and a 52-week high of $315.99.

Union Pacific (NYSE:UNP – Get Free Report) last posted its earnings results on Thursday, July 23rd. The railroad operator reported $3.41 earnings per share for the quarter, topping analysts’ consensus estimates of $3.26 by $0.15. The company had revenue of $6.86 billion during the quarter, compared to analyst estimates of $6.72 billion. Union Pacific had a return on equity of 38.46% and a net margin of 28.85%.Union Pacific’s revenue was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.03 earnings per share. On average, sell-side analysts anticipate that Union Pacific Corporation will post 12.93 EPS for the current fiscal year. Union Pacific Increases Dividend The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Monday, August 31st will be given a dividend of $1.42 per share. The ex-dividend date of this dividend is Monday, August 31st. This is an increase from Union Pacific’s previous quarterly dividend of $1.38. This represents a $5.68 dividend on an annualized basis and a yield of 1.8%. Union Pacific’s dividend payout ratio is 44.70%.

Insiders Place Their Bets In other Union Pacific news, EVP Eric J. Gehringer sold 2,991 shares of Union Pacific stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $263.96, for a total value of $789,504.36. Following the transaction, the executive vice president owned 43,012 shares in the company, valued at $11,353,447.52. The trade was a 6.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.22% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth Several research firms have recently weighed in on UNP. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Union Pacific in a research note on Monday, July 13th. BMO Capital Markets reaffirmed a “market perform” rating and set a $320.00 target price (up from $285.00) on shares of Union Pacific in a research report on Friday, July 24th. Robert W. Baird upped their target price on Union Pacific from $311.00 to $344.00 and gave the stock an “outperform” rating in a report on Monday, July 27th. Benchmark increased their price target on Union Pacific from $325.00 to $335.00 and gave the stock a “buy” rating in a research report on Friday, July 24th. Finally, Susquehanna raised their price target on Union Pacific from $305.00 to $333.00 and gave the company a “positive” rating in a research note on Tuesday, July 14th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $320.89.

Check Out Our Latest Stock Report on Union Pacific

About Union Pacific (Free Report)

Union Pacific Corporation (NYSE: UNP) is one of the largest freight railroad companies in the United States. Its principal operating subsidiary, Union Pacific Railroad, has roots that trace back to the Pacific Railway Act of 1862 and the construction of the first transcontinental rail link completed in 1869. The company is headquartered in Omaha, Nebraska, and operates as a holding company for rail transportation and related services.

Union Pacific’s core business is the movement of freight by rail across an extensive rail network serving the western two‑thirds of the United States.

See Also Five stocks we like better than Union Pacific VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over Want to see what other hedge funds are holding UNP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Union Pacific Corporation (NYSE:UNP – Free Report).

Receive News & Ratings for Union Pacific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Union Pacific and related companies with MarketBeat.com's FREE daily email newsletter.

Biondo Investment Advisors LLC bought a new stake in shares of General Dynamics Corporation (NYSE:GD – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 25,075 shares of the aerospace company’s stock, valued at approximately $8,883,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GD. Whipplewood Advisors LLC increased its position in General Dynamics by 1,725.0% during the 1st quarter. Whipplewood Advisors LLC now owns 73 shares of the aerospace company’s stock valued at $25,000 after purchasing an additional 69 shares during the period. Scarborough Advisors LLC bought a new stake in shares of General Dynamics during the 1st quarter valued at about $29,000. Wilkerson Advisory Group LLC boosted its stake in shares of General Dynamics by 79.6% during the 1st quarter. Wilkerson Advisory Group LLC now owns 88 shares of the aerospace company’s stock valued at $30,000 after purchasing an additional 39 shares in the last quarter. Paladin Partners LLC purchased a new position in shares of General Dynamics during the second quarter valued at about $30,000. Finally, Center for Financial Planning Inc. raised its stake in General Dynamics by 220.7% in the fourth quarter. Center for Financial Planning Inc. now owns 93 shares of the aerospace company’s stock worth $31,000 after buying an additional 64 shares in the last quarter. Institutional investors own 86.14% of the company’s stock.

Wall Street Analysts Forecast Growth Several research analysts have recently issued reports on GD shares. UBS Group increased their target price on General Dynamics from $366.00 to $395.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. DA Davidson decreased their price objective on General Dynamics from $384.00 to $375.00 in a report on Thursday, April 30th. TD Cowen raised their price objective on General Dynamics from $390.00 to $420.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. Susquehanna boosted their target price on shares of General Dynamics from $420.00 to $455.00 and gave the company a “positive” rating in a report on Thursday, July 30th. Finally, Royal Bank Of Canada increased their price target on shares of General Dynamics from $385.00 to $410.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, General Dynamics presently has a consensus rating of “Moderate Buy” and an average target price of $410.89.

View Our Latest Stock Analysis on General Dynamics Insider Buying and Selling In other news, EVP Marguerite Amy Gilliland sold 43,180 shares of the business’s stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $378.04, for a total value of $16,323,767.20. Following the transaction, the executive vice president directly owned 44,767 shares in the company, valued at $16,923,716.68. The trade was a 49.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Mark Malcolm sold 5,480 shares of the business’s stock in a transaction that occurred on Wednesday, June 17th. The stock was sold at an average price of $365.00, for a total value of $2,000,200.00. Following the completion of the transaction, the director directly owned 10,643 shares in the company, valued at approximately $3,884,695. This represents a 33.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 100,228 shares of company stock valued at $38,052,853. Company insiders own 1.40% of the company’s stock.

General Dynamics Price Performance Shares of GD opened at $384.50 on Monday. The firm has a market cap of $104.03 billion, a PE ratio of 23.46, a P/E/G ratio of 2.22 and a beta of 0.32. General Dynamics Corporation has a 1-year low of $306.77 and a 1-year high of $400.00. The company has a current ratio of 1.44, a quick ratio of 0.96 and a debt-to-equity ratio of 0.23. The firm has a fifty day simple moving average of $374.15 and a two-hundred day simple moving average of $355.88.

General Dynamics (NYSE:GD – Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The aerospace company reported $4.24 earnings per share for the quarter, topping the consensus estimate of $3.96 by $0.28. General Dynamics had a net margin of 8.18% and a return on equity of 17.43%. The firm had revenue of $14.09 billion for the quarter, compared to analysts’ expectations of $13.52 billion. During the same quarter in the prior year, the business earned $3.74 EPS. The business’s quarterly revenue was up 8.1% on a year-over-year basis. General Dynamics has set its FY 2026 guidance at 16.800-16.900 EPS. On average, equities analysts anticipate that General Dynamics Corporation will post 16.97 EPS for the current year.

General Dynamics Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 9th will be paid a dividend of $1.59 per share. The ex-dividend date is Friday, October 9th. This represents a $6.36 dividend on an annualized basis and a dividend yield of 1.7%. General Dynamics’s payout ratio is 38.80%.

General Dynamics Profile (Free Report)

General Dynamics is a major American aerospace and defense contractor that designs, manufactures and supports a broad range of products and services for government and commercial customers worldwide. Headquartered in the United States (Reston, Virginia), the company supplies platforms and systems used by armed forces, civil authorities and private operators across multiple domains including air, land, sea and cyber.

Its principal activities span several operating businesses: a business aviation unit that develops and supports Gulfstream business jets; land systems that produce armored combat vehicles and related logistics and sustainment services; marine systems that design and construct submarines and surface ships for navies; and mission systems and information technology operations that provide command-and-control, communications, cybersecurity and systems-integration services.

Featured Articles Five stocks we like better than General Dynamics VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over Want to see what other hedge funds are holding GD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for General Dynamics Corporation (NYSE:GD – Free Report).

Receive News & Ratings for General Dynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for General Dynamics and related companies with MarketBeat.com's FREE daily email newsletter.